ondansetron has been researched along with granisetron in 270 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (0.74) | 18.7374 |
| 1990's | 135 (50.00) | 18.2507 |
| 2000's | 81 (30.00) | 29.6817 |
| 2010's | 41 (15.19) | 24.3611 |
| 2020's | 11 (4.07) | 2.80 |
| Authors | Studies |
|---|---|
| Airey, JE; Campbell, HF; Darkes, P; Fitzpatrick, LR; Klein, S; Neuenschwander, K; Pendley, CE; Powers, M; Schnapper, M; Youssefyeh, RD | 1 |
| Hayashi, H; Ichikawa, S; Ishii, A; Kono, M; Miki, I; Miwa, Y; Suzuki, F; Yoda, N | 1 |
| Airey, JE; Campbell, HF; Golec, S; Klein, S; Powers, M; Rodriguez, W; Schnapper, M; Studt, W; Woodward, R; Youssefyeh, RD | 1 |
| Bloomquist, W; Cohen, ML; Reid, LR; Robertson, DW; Schenck, K; Wong, DT | 1 |
| Carr, AA; Hibert, MF; Hoffmann, R; Miller, RC | 1 |
| Bermudez, J; Fake, CS; Joiner, GF; Joiner, KA; King, FD; Miner, WD; Sanger, GJ | 1 |
| Hayashi, H; Ichikawa, S; Ishii, A; Kishibayashi, N; Miwa, Y; Nonaka, H; Suzuki, F; Yokoyama, T | 1 |
| de Jonge, A; Hamminga, D; Mol, F; Olivier, B; Standaar, PJ; Tipker, J; Tulp, MT; van Hes, R; van Wijngaarden, I | 1 |
| Berger, J; Bonhaus, DW; Clark, RD; Eglen, RM; Kowalczyk, BA; Lee, CH; Michel, AD; Miller, AB; Repke, DB; Weinhardt, KK | 1 |
| Hayashi, H; Ichikawa, S; Ishii, A; Kono, M; Miki, I; Miwa, Y; Suzuki, F; Yasuzawa, T; Yoda, N | 1 |
| Arrigoni, C; Bolis, G; Caccia, C; Dho, L; Heidempergher, F; McArthur, R; Pillan, A; Pinciroli, V; Vaghi, F; Varasi, M | 1 |
| Bourguignon, JJ; Didier, B; Hoffmann, R; Rival, Y; Rybaltchenko, V; Wermuth, CG | 1 |
| Alfaro, MJ; Benhamú, B; López-Rodríguez, ML; Martín, MI; Morcillo, MJ; Orensanz, L; Tejada, ID | 1 |
| Gordon, JC; Gurley, D; Lanthorn, T; Loch, J; Mack, RA; Macor, JE; Mullen, G; Tran, O; Wright, N | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Barnes, NM; Brady, CA; Butler, AS; Choo, SH; Cioffi, CL; Cohen, ML; Dobritsa, S; Earley, WG; Fitzpatrick, K; Guo, C; Guzzo, PR; Hassler, C; Manning, DD; Masih, L; Naginskaya, J; Ryan, KN; Sikkander, MI; Usyatinsky, A; Wierschke, JD; Zhang, Z | 1 |
| Sen, S; Sinha, N | 1 |
| Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bojarski, AJ; Dehaen, W; Janousek, J; Juza, R; Karasova, JZ; Kobrlova, T; Korabecny, J; Kubacka, M; Mezeiova, E; Mogilski, S; Musilek, K; Pejchal, J; Petrasek, T; Prchal, L; Randakova, A; Satala, G; Soukup, O; Stark, H; Stefkova-Mazochova, K; Svozil, D; Vlcek, P; Vojtechova, I | 1 |
| Andrews, PL; Bhandari, P; Bingham, S; Blower, PR; Davey, PT; Marr, HE | 1 |
| Dilly, S | 1 |
| Andrews, PL; Bingham, S; Joel, SP; Patel, N; Slevin, ML; Thompson, PI | 1 |
| Sakamori, M; Setoguchi, M; Takehara, S | 1 |
| Bosanquet, N; Jones, AL; Lee, GJ | 1 |
| Cassuto, J; Jodal, M; Lundgren, O; Sjöqvist, A | 1 |
| Barnes, NM; Cheng, CH; Costall, B; Ge, J; Kelly, ME; Naylor, RJ | 1 |
| Aapro, M; Diehl, V; Kaye, SB; Khayat, D | 1 |
| Soukop, M | 1 |
| Smith, RA | 1 |
| Ito, H; Iwai, A; Kamato, T; Katsuyama, Y; Miyata, K; Nishida, A; Ohta, M; Tsutsumi, R; Yamano, M; Yuki, H | 1 |
| Andrews, PL; Bhandari, P | 1 |
| Higgins, GA; Jones, BJ; Oakley, NR; Tyers, MB | 1 |
| de Mulder, PH; Seynaeve, C; Verweij, J | 1 |
| Jantunen, I; Johansson, R | 1 |
| Itoh, Z; Iwanaga, Y; Mizumoto, A; Yoshida, N | 1 |
| Itoh, Z; Iwanaga, Y; Mizumoto, A; Torii, K; Wakabayashi, K; Yoshida, N | 1 |
| Gandara, DR; Hesketh, PJ | 1 |
| Airey, JE; Bostwick, JS; Decktor, DL; Fitzpatrick, LR; Gessner, GW; Lambert, RM; Martin, GE; Pendleton, RG; Pendley, CE; Youssefyeh, RD | 1 |
| Moss, HE; Sanger, GJ | 1 |
| Brown, GW; Butcher, ME; Kidgell, AE | 1 |
| File, SE; Johnston, AL | 1 |
| Ito, A; Ito, T; Iwanaga, H; Karasawa, T; Mizumoto, A; Yoshida, N | 1 |
| Akuzawa, S; Ito, H; Kamato, T; Kiso, T; Miyata, K; Nishida, A; Tsutsumi, R; Yamano, M | 1 |
| Behnam Motlagh, P; Grankvist, K; Henriksson, R | 1 |
| Blaney, FE; Edge, C; Phippen, RW | 1 |
| Blower, P; Grélot, L; Milano, S; Romain, D | 1 |
| Bremer, K; Cupissol, D; Dilly, SG; Goedhals, L; Noble, A | 1 |
| Allison, K; Arnold, B; Greenshaw, AJ; Ivanová, S; Paetsch, PR; Paslawski, T | 1 |
| Blauw, GJ; Bruning, TA; Chang, PC; van Zwieten, PA; Vermeij, P | 1 |
| Perez, EA | 2 |
| Fitts, D; Friedman, C; Gandara, D; Hall, S; Hesketh, P; Mailliard, J; Navari, R; Ritter, H | 1 |
| Clark, R; Eglen, RM; Hegde, SS; Johnson, LG; Lee, CH; Smith, WL; Whiting, RL | 1 |
| Bosanquet, N; Johnson, N | 1 |
| Honda, K; Ito, H; Kamato, T; Miyata, K; Nishida, A; Tsutsumi, R; Yamano, M; Yuki, H | 1 |
| Bridal, TR; de Lorenzi, FG; Spinelli, W | 1 |
| Ayrton, AD; Baldwin, SJ; Bloomer, JC; Chenery, RJ; Clarke, SE; Smith, GJ | 1 |
| Anthony, EW; Nevins, ME | 1 |
| Godefroid, RJ; Harrison, BR | 1 |
| Perry, MR; Rhee, J; Smith, WL | 1 |
| Del Favero, A; Roila, F; Tonato, M | 1 |
| Daniels, S; Eglen, RM; Fontana, DJ; Khabbaz, M; Kilfoil, T; Lee, CH; Wong, EH | 1 |
| Cannata, G; Cipolla, C; Curto, G; Gebbia, N; Gebbia, V; Latteri, MA; Testa, A; Valenza, R | 1 |
| Brown, NJ; Horton, A; Read, NW; Rumsey, RD | 1 |
| Fukuda, T; Haga, K; Inaba, K; Morimoto, Y; Setoguchi, M; Shoji, H | 1 |
| Ichikawa, S; Ishii, A; Karasawa, A; Kishibayashi, N; Yokoyama, T | 1 |
| Kirchner, V | 1 |
| Calderó, JM; del Río, J; García, E; Lasheras, B; Monge, A; Palop, JA; Peña, MC; Roca, J; Romero, G | 1 |
| Essien, E; Thut, PD; Wynn, RL | 1 |
| Beubler, E; Gamse, R; Schirgi-Degen, A | 1 |
| Ohta, J; Taguchi, T; Tsukagoshi, S | 1 |
| Grahame-Smith, DG; Leslie, RA; Pei, Q; Zetterström, T | 1 |
| Barnes, JM; Barnes, NM | 1 |
| Snyman, JR; Sommers, DK; van Wyk, M | 1 |
| Aapro, MS | 3 |
| Flander, MK; Jantunen, IT; Kataja, VV; Muhonen, TT; Teerenhovi, L | 1 |
| Blackburn, TP; Grahame-Smith, DG; Leslie, RA; Newberry, NR; Sprosen, TS; Watkins, CJ | 1 |
| Fujiwara, I; Harada, H; Hirokawa, Y; Kato, S; Morie, T; Terauchi, H; Yoshida, N | 1 |
| de Bruijn, KM; Kataja, V | 1 |
| Bianchi, A; Curreli, L; Ghiani, M; Macciò, A; Mantovani, G; Proto, E; Santona, MC | 1 |
| Hickok, JT; Morrow, GR; Rosenthal, SN | 1 |
| Collini, D; Fedele, P; Lucia, C; Manicone, M; Spina, M; Tirelli, U; Valentini, M | 1 |
| Barbato, F; La Rotonda, MI; Quaglia, F | 1 |
| Galindo, JR | 1 |
| Angelelli, B; Guaraldi, M; Martoni, A; Pannuti, F; Strocchi, E | 1 |
| Akuzawa, S; Kamato, T; Miyata, K; Yamano, M | 1 |
| Alon, E; Biro, P | 1 |
| Parasuraman, TV; Paska, W; Thwaites, R | 1 |
| Bonneterre, J; Hecquet, B | 1 |
| Ionta, MT; Massidda, B | 1 |
| Cassoni, AM; Gibbs, SJ | 1 |
| Quigley, C | 1 |
| Attia, M; Channa, AB; el Bakry, AK; el Gammal, K; el Gammal, M; Elhattab, YS; Jaroudi, R; Khoshim, MH; Naguib, M; Saddique, A | 1 |
| Alberts, VA; Catalano, G; Poole, MA | 1 |
| Holder, EP | 1 |
| Bueno, L; Fioramonti, J; Rouzade, ML | 1 |
| Cubeddu, LX; Cupissol, D; Gralla, RJ; Homesley, HD; Kris, MG; Tyson, LB; Venkatraman, E | 1 |
| Teixeira, GM; Tremont-Lukats, IW | 1 |
| Gershon, MD; Kadowaki, M; Wade, PR | 1 |
| Kobayashi, S; Kumai, T; Nakura, H; Tanaka, M; Tateishi, T; Watanabe, M | 1 |
| Grondahi, ML; Hansen, MB; Jensen, GM; Skadhauge, E | 1 |
| Dahl, SG; Junien, JL; Langlois, A; Pascaud, X; Rivière, PJ | 1 |
| Tsukagoshi, S | 1 |
| Boike, SC; Ilson, B; Jorkasky, DK; Zariffa, N | 1 |
| Benline, TA; French, J | 1 |
| Kamato, T; Miyata, K; Nagakura, Y; Yamano, M | 1 |
| Basurto, C; Ciccarese, G; Palladino, MA; Roila, F | 1 |
| Graf, S; Sarna, SK | 1 |
| Cunningham, RS | 1 |
| Saphir, A | 1 |
| Bernstein, G; Colgan, K; Dempsey, CL; Farley, PA; Kulis-Robitaille, C; Shillington, AA | 1 |
| Benline, TA; French, J; Poole, E | 1 |
| Chung, HC; Kim, BS; Kim, JH; Min, JS; Park, JO; Rha, SY; Roh, JK; Yoo, NC | 1 |
| Kaisar, M; Naylor, RJ; Tuladhar, BR | 1 |
| Burish, T; Flynn, PJ; Hynes, HE; Morrow, GR; Pierce, HI; Roscoe, JA | 1 |
| Bushnell, W; Chawla, S; Friedman, C; Hainsworth, J; Hesketh, P; Markman, M; Perez, EA; Reeves, J; Sandbach, J | 1 |
| Baltzer, L; Berkery, R; Grossano, D; Kris, MG; Lucarelli, CD; Nolte, MJ; Pizzo, B | 1 |
| Bushnell, W; Einhorn, L; Ettinger, D; Friedman, C; Gralla, RJ; Hesketh, PJ; Navari, RM; Noy, J; Popovic, W; Strupp, J | 1 |
| Agay, D; Fatôme, M; Martin, C; Roman, V | 1 |
| Chow, LW; Poon, RT | 1 |
| Bolwell, B; Boparai, N; Jones, E; Kalaycio, M; Mendez, Z; Overmoyer, B; Pohlman, B | 1 |
| Farthing, MJ | 1 |
| Ben Dayan, D; Ben Zion, T; Cohen, AM; Kaufman, O; Mittelman, M; Zeidman, A | 1 |
| Ngan, MP; Rudd, JA; Wai, MK | 1 |
| Bleuse, JP; Block, S; Bonneterre, J; Bonneterre, ME; Carlier, D; Darloy, F; Fournier, C; Huc, P | 1 |
| Alianti, J; Corrigan, BW; Grosse, C; Lam, R; Nicholls, B; Palmer, JL; Thakrar, B | 1 |
| Maksay, G | 1 |
| Fisher, DM | 1 |
| McQuay, HJ; Moore, RA; Reynolds, DJ; Stoner, NS; Tramèr, MR | 1 |
| Baltali, E; Barişta, I; Ozişik, Y; Tekuzman, G; Yalçin, S | 1 |
| Gerbino, PP; Goldsmith, M; Kenney, JT; Lindley, C; Nolte, J; Quan, W; Reich, PR | 1 |
| Granisétron, PK; Mabro, M | 1 |
| Behnam-Motlagh, P; Engström, KG; Grankvist, K; Henriksson, R | 1 |
| Ozaki, A; Sukamoto, T | 1 |
| Perez, EA; Solberg, LA; Tiemeier, T | 1 |
| Castejon, AM; Cubeddu, LX; Hernandez, L; Paez, X | 1 |
| Burns, L; DeFor, TE; Larson, H; Orchard, PJ; Ramsay, NK; Rogosheske, J; Rydholm, N; Weisdorf, D | 1 |
| Blower, PR; Endo, T; Hamaue, N; Hirafuji, M; Kitamura, N; Minami, M; Nemoto, M; Ogawa, T; Teramoto, Y; Yasuda, E | 1 |
| Bacci, G; Beghelli, C; Biolchini, A; Ferrari, S; Forni, C; Loro, L; Mazzei, T; Puggioli, C; Simoni, P; Strazzari, S; Tremosini, M | 1 |
| Alkiş, N; Kartum, A; Oge, A; Oge, O | 1 |
| Chan, R; Chua, DT; Foo, YC; Kwok, CC; Kwong, DL; Sham, JS; Yue, A | 1 |
| Akutagawa, N; Ishioka, S; Ito, E; Kiya, T; Kudo, R; Sagae, S; Saito, T; Sugimura, M; Umemura, K | 1 |
| Baron, PL; Cole, DJ; Maize, JC; McClay, EF; McClay, ME; Metcalf, JS; Monroe, L; O'Brien, PH | 1 |
| Bushnell, W; Frankel, SR; Friedman, CJ; Raschko, J; Spitzer, TR | 1 |
| Barrajon, E; de las Peñas, R | 1 |
| Benedict, CR; Brown, AM; Kuryshev, YA; Rampe, D; Wang, L | 1 |
| Chen, PM; Chiou, TJ; Fan, FS; Liu, JH; Tzeng, WF; Wang, WS; Yen, CC | 1 |
| Herrington, JD; Kwan, P; Lagow, E; Lagrone, L; Riggs, MW; Young, RR | 1 |
| Chillas, JC; Knox, GW; Levine, ME; Stern, RM | 1 |
| Klener, P; Procházka, B; Slabý, J; Trnený, M | 1 |
| Araújo Pereira, ME; Carmo, JA; Juncal, C; Lacerda, JF; Lacerda, JM; Lourenço, MF; Martins, C; Rodrigues, A | 1 |
| Naylor, RJ; Tuladhar, BR; Womack, MD | 1 |
| Caparroz, C; Castro, PC; del Giglio, A; Soares, HP | 1 |
| Bingham, A; Houston, SA; Lindley, CM; McCune, JS; Oertel, MD; Pfeifer, D; Sawyer, WT | 1 |
| Horikoshi, K; Ishii, A; Karasawa, A; Kishibayashi, N; Ohmori, K; Yokoyama, T | 1 |
| Behnam-Motlagh, P; Grankvist, K; Henriksson, R; Sandström, PE | 2 |
| de Boer, AC; de Wit, R; Sparreboom, A; Stoter, G; vd Linden, GH; Verweij, J | 1 |
| Fisher, SG; Fletcher-Gonzalez, D; Fox-Geiman, MP; Kiley, K; Porter, N; Stiff, P | 1 |
| Allgar, V; Goss, I; Overend, M; Pedley, I; Riley, M; Watters, J; Whitehead, A | 1 |
| Keefe, DL | 1 |
| Akamatsu, H; Mikawa, K; Nishina, K; Niwa, Y; Shiga, M | 1 |
| Kulp, B; Markman, M; Markman, MR; Peterson, G | 1 |
| Aapro, M; Blower, P | 1 |
| Markman, M | 1 |
| Chen, Y; Cheng, G; Feng, F; He, Y; Li, Y; Zhang, P; Zhou, M | 1 |
| Lograno, MD; Romano, MR | 1 |
| Aapro, M; Carides, AD; Evans, JK; Hargreaves, R; Hesketh, PJ; Horgan, KJ; Naylor, RJ; Tattersall, FD; Van Belle, S | 1 |
| Cheng, JT; Johnston, KD; Kan, KK; Ngan, MP; Rudd, JA; Sam, TS; Wai, MK; Yeung, JH | 1 |
| Blum, RA; Busillo, J; Goldberg, MR; Gottesdiener, KM; Greenberg, HE; Hesney, M; Hustad, CM; Kraft, WK; Lates, C; Majumdar, A; McCrea, J; Murphy, MG; Orlowski, LH; Panebianco, D; Petty, KJ; Van Buren, S; Waldman, SA | 1 |
| Martinez, JF; Trissel, LA | 1 |
| Koeller, JM; Navari, RM | 1 |
| Tan, M | 1 |
| Coop, AJ; Dempsey, CL; Eberhardt, DR; Farley, PA; O'Briant, S; Shillington, A | 1 |
| Aiello, R; Conti, G; Dimari, A; Mauceri, G; Tralongo, P | 1 |
| Domínguez, J; García-Alloza, M; Gil-Bea, FJ; Lasheras, B; Marcos, B; Ramírez, MJ | 1 |
| Endo, T; Hamaue, N; Hirafuji, M; Minami, M | 1 |
| Goldsmith, B | 1 |
| Bradshaw, P; Callander, N; Clark, G; Freytes, CO; Holle, LM; Morris, AK; Valley, AW; Walsh, T | 1 |
| Zielinski, SL | 1 |
| Bhatnagar, S; Dua, N; Mishra, S; Singhal, AK | 1 |
| Bousquet, PJ; Co-Minh, HB; Demoly, P | 1 |
| Buyukavci, M; Ceviz, N; Olgun, H | 1 |
| Olver, IN | 1 |
| Coop, A; Gan, TJ; Philip, BK | 1 |
| Cartwright, J; Frangoul, H; Ho, RH; Jones, E; Koyama, T; Kuttesch, J; Shankar, S; Whitlock, JA | 1 |
| Aapro, M; Rabaeus, M | 1 |
| Acar, S; Baysal, K; Dagdemir, A; Elli, M; Pinarli, FG | 1 |
| Abali, H; Aynacioglu, AS; Babaoglu, MO; Bayar, B; Bozkurt, A; Celik, I; Kerb, R | 1 |
| Doulaveris, P; Myhand, R; Sano, HS; Solimando, DA; Waddell, JA | 1 |
| Nylander, O; Pihl, L | 1 |
| Board, R; Board, T | 1 |
| Cunneen, S; Hamza, MA; Kariger, R; Khalili, T; Lo, M; Naruse, R; Ogunnaike, B; Sloninsky, A; Tang, J; Wender, RH; White, PF | 1 |
| Neustein, SM | 1 |
| del Giglio, A; Lajolo, PP | 1 |
| Awab, A; Chaudhary, L; Hamadani, M; Tfayli, A | 1 |
| Neufeld, SM; Newburn-Cook, CV | 1 |
| Arnold, D; Grothey, A; Hinke, A; Jordan, K; Schmoll, HJ; Voigt, W; Wolf, HH | 1 |
| Aouad, MT; Azar, MS; Baraka, AS; Hakki, MA; Kaddoum, RN; Nasr, VG; Siddik-Sayyid, SM; Taha, SK; Yazbek, VG | 1 |
| Hashimoto, R; Ikeda, K; Kurokawa, N; Okamoto, Y; Takagi, T; Takenaka, M; Ueda, T; Uejima, E | 1 |
| Quan, X; Ye, TH; Zhu, B | 2 |
| Arheart, KL; Birnbach, DJ; Candiotti, KA; Deepika, K; Kamat, A; Lubarsky, DA; Nhuch, F | 1 |
| Wilkes, G | 1 |
| Awan, FT; Chaudhary, L; Hamadani, M; Khan, JK; Kojouri, K; Ozer, H; Tfayli, A | 1 |
| Aydede, H; Erhan, E; Erhan, Y; Yentur, A; Yumus, O | 1 |
| Arora, R; Bhatnagar, S; Gupta, D; Mishra, S; Singh, M; Srikanti, M | 1 |
| Vrabel, M | 1 |
| Ezberci, M; Oksuz, H; Zencirci, B | 1 |
| Barbaud, A; Bursztejn, AC; Cuny, JF; Schmutz, JL; Tréchot, P | 1 |
| Alt, J; Cantoreggi, S; Massuda, EB; Rojas, C; Rubenstein, E; Sebastiani, S; Slusher, B; Snyder, SH; Stathis, M; Thomas, AG; Zhang, J | 1 |
| Szántó, J; Tóth, J | 1 |
| Du Bois, A | 1 |
| Bithal, PK; Dash, HH; Jain, V; Mitra, JK; Prabhakar, H; Rath, GP | 1 |
| Carey, M; Choroszczak, P; Immani, S; Ojo, R; Tan, T | 1 |
| Marouf, H; Riad, W | 1 |
| Ayuhara, H; Okuyama, K; Ozeki, T; Takayanagi, R; Yamada, Y; Yokoyama, H; Yoshimoto, K | 1 |
| Billio, A; Clarke, MJ; Morello, E | 2 |
| Aoyama, T; Hattori, T; Kato, S; Kurosawa, S; Nahata, M; Ohno, S; Ro, S; Sakurada, T; Takabayashi, H; Tamai, M; Yakabi, K; Yuzurihara, M | 1 |
| Baraka, AS; Dabbous, AS; El-Khatib, MF; Jabbour-Khoury, SI; Khouzam, NE; Moussa, AA; Nasr, VG; Zbeidy, RA | 1 |
| Aouad, M; Siddik-Sayyid, SM | 1 |
| Batu, ED; Büyükpamukçu, M; Civelek, E; Demir, HA; Saçkesen, C; Yalçın, B | 1 |
| Askitopoulou, H; Chatzimichali, A; Metaxari, M; Papaioannou, A; Petrou, A; Pharmakalidou, E | 1 |
| Hafiz, MG; Islam, A; Jamal, CY; Rokeya, B; Siddique, R | 1 |
| Drdla-Schutting, R; Heinl, C; Sandkühler, J; Xanthos, DN | 1 |
| Basu, A; Hembrom, BP; Naaz, A; Roy, A; Saha, D | 1 |
| Dougherty, DA; Duffy, NH; Lester, HA | 1 |
| Eksborg, S; Lönnqvist, PA; Öbrink, E; Oddby-Muhrbeck, E; Rotstein, S | 1 |
| Cheng, NS; Lin, YX; Wu, SJ; Xiong, XZ | 1 |
| Iwata, N; Kishi, T; Matsuda, Y; Mukai, T | 1 |
| Ballinari, G; Barbour, SY; Cox, D; Morrow, GR; Schwartzberg, L; Thorn, MD | 1 |
| Brygger, L; Herrstedt, J | 1 |
| Du, Y; Lin, X; Liu, J; Ni, J; Tang, Y; Zeng, K; Zhou, J | 1 |
| Chow, E; DeAngelis, C; Hunyh, L; McDonald, R; Pasetka, M; Raman, S; Rowbottom, L | 1 |
| Horita, H; Hotta, H; Kato, R; Kitamura, H; Kunishima, Y; Masumori, N; Takahashi, A; Takei, F | 1 |
| Arora, S; Chasen, M; Navari, R; Powers, D; Rapoport, B; Schnadig, I; Schwartzberg, L | 1 |
| Agajanian, R; Cooper, W; Dakhil, C; Gabrail, NY; Klepper, MJ; Mosier, MC; Payne, JY; Schnadig, ID; Schwartzberg, LS; Smith, RE; Taylor, C; Vacirca, JL; Wilks, ST | 1 |
| Hou, F; Le, Q; Li, H; Li, W; Liu, S; Shi, Q; Zheng, L; Zong, S | 1 |
| Asada, K; Enomoto, N; Fujisawa, T; Hayakawa, H; Imokawa, S; Inui, N; Karayama, M; Kuroishi, S; Masuda, M; Nakamura, Y; Suda, T; Suzuki, S; Toyoshima, M; Watanabe, H; Yamada, T; Yokomura, K | 1 |
| Du, Q; Xu, XL; Yu, B; Zhai, Q; Zhu, B | 1 |
| Arora, MK; Borle, A; Gouda, D; Goudra, B; Makkar, JK; Singh, PM; Sinha, A; Trikha, A | 1 |
| Abushouk, AI; Ahmed, H; Al Nahrawi, S; Attia, A; Awad, K; Elsherbeny, MY; Mustafa, SM | 1 |
| Liu, Z; Ruan, L; Zhou, C; Zhu, Y | 1 |
| Bernhardt, MB | 1 |
| Coboeken, K; Dallmann, A; Eissing, T; Hempel, G; Ince, I | 1 |
| Huang, C; Li, J; Sun, Y; Wan, H; Wang, Q; Zhang, H; Zhang, J; Zhong, H | 1 |
| Ahamed, S; Begum, M; Begum, R; Chowdhury, MG; Hossain, M; Hossain, MM; Shuvo, FR | 1 |
| Abdolrazaghnejad, A; Aghakarim Alamdar, M; Ebrahimi-Monfared, M; Massoudifar, A; Mohammadbeigi, A; Saber, R; Sharafkhah, M | 1 |
| Barakat, GH; El-Bagary, RI; Hassib, ST; Taha, EA | 1 |
| Burckart, G; Garimella, N; Griebel, D; Heinrichs, MT; Kim, I; Krudys, K; Kumar, S; Mehrotra, N; Momper, JD; Mulberg, AE; Mulugeta, Y; Nelson, R; Reaman, G; Sachs, H; Sinha, V; Yao, L; Zineh, I | 1 |
| Acosta-Reyes, J; Florez, ID; Niño-Serna, LF; Veroniki, AA | 1 |
| Armbruster, SD; Coleman, RL; Eifel, PJ; Fellman, BM; Frumovitz, M; Jhingran, A; Klopp, AH; Ramondetta, LM | 1 |
| Hayes, AW; Jafarian, AH; Karimi, G; Mehri, S; Rahimian, R; Zirak, MR | 1 |
| Aizawa, F; Chuma, M; Goda, M; Hamano, H; Ishizawa, K; Izawa-Ishizawa, Y; Kanda, M; Murai, Y; Niimura, T; Okada, N; Yagi, K; Yoshida, A; Yoshioka, T; Zamami, Y | 1 |
| Eom, YA; Jin, JY; Kang, JH; Kim, HK; Ko, YH; Park, SY; Sun, S; Woo, IS | 1 |
| Albraithen, AA; Arafa, SK; Elsayed, AA; Shama, AAA | 1 |
| Ebrahimian, M; Ghayebi, N; Kialashaki, M; Mirhashemi, SH; Oshidari, B; Shadidi-Asil, R; Zamani, A | 1 |
| Maiti, R; Mishra, A; Mishra, BR; Srinivasan, A | 1 |
48 review(s) available for ondansetron and granisetron
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Are granisetron and ondansetron equivalent in the clinic?
Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Granisetron; Humans; Imidazoles; Indazoles; Nausea; Ondansetron; Serotonin Antagonists; Vomiting | 1992 |
5-hydroxytryptamine-3 antagonists: a new class of potent antiemetics in cancer therapy.
Topics: Animals; Antiemetics; Granisetron; Humans; Imidazoles; Indazoles; Ondansetron; Serotonin Antagonists | 1991 |
5-HT3 receptor antagonists, a new approach in emesis: a review of ondansetron, granisetron and tropisetron.
Topics: Animals; Antiemetics; Granisetron; Humans; Imidazoles; Indazoles; Indoles; Ondansetron; Serotonin Antagonists; Tropisetron; Vomiting | 1991 |
[Chemotherapy-induced emesis and serotonin antagonists].
Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Indoles; Ondansetron; Serotonin Antagonists; Tropisetron; Vomiting | 1991 |
Antiemetic control: 5-HT3 antagonists: review of clinical results, with particular emphasis on ondansetron.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Granisetron; Headache; Humans; Imidazoles; Indazoles; Indoles; Nausea; Ondansetron; Radiation Injuries; Radiotherapy; Serotonin Antagonists; Tropisetron; Vomiting | 1990 |
Review of the preclinical pharmacology and comparative efficacy of 5-hydroxytryptamine-3 receptor antagonists for chemotherapy-induced emesis.
Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Granisetron; Humans; Indoles; Ondansetron; Prognosis; Selective Serotonin Reuptake Inhibitors; Tropisetron; Vomiting | 1995 |
Are there differences among the serotonin antagonists?
Topics: Animals; Antiemetics; Cisplatin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Granisetron; Humans; Indoles; Neoplasms; Ondansetron; Serotonin Antagonists; Tropisetron; Vomiting | 1994 |
Clinical studies to assess the economic impact of new therapies: pragmatic approaches to measuring costs.
Topics: Antiemetics; Clinical Trials as Topic; Cost-Benefit Analysis; Costs and Cost Analysis; Drug Therapy, Combination; Granisetron; Humans; Metoclopramide; Ondansetron; Serotonin Antagonists | 1993 |
[An outline of 5-HT3 receptor antagonists (2)--In clinical applications].
Topics: Antineoplastic Agents; Granisetron; Humans; Metoclopramide; Nausea; Ondansetron; Serotonin Antagonists; Vomiting | 1993 |
Review of experience with ondansetron and granisetron.
Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Indazoles; Nausea; Ondansetron; Serotonin Antagonists; Vomiting | 1993 |
Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban).
Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Indoles; Nausea; Ondansetron; Serotonin Antagonists; Tropisetron; Vomiting | 1995 |
[Anti-5-HT-3: a new group of antiemetics].
Topics: Adult; Antiemetics; Granisetron; Humans; Indoles; Ondansetron; Serotonin Antagonists; Time Factors; Tropisetron | 1996 |
[Prevention and treatment of postoperative nausea and vomiting with 5-HT3-receptor blockers].
Topics: Antiemetics; Clinical Trials as Topic; Dose-Response Relationship, Drug; Granisetron; Humans; Indoles; Infusions, Intravenous; Nausea; Ondansetron; Postoperative Complications; Quinolizines; Serotonin Antagonists; Tropisetron; Vomiting | 1996 |
Are more antiemetic trials with a placebo necessary? Report of patient data from randomized trials of placebo antiemetics with cisplatin.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Double-Blind Method; Female; Granisetron; Humans; Male; Metoclopramide; Middle Aged; Ondansetron; Placebos; Randomized Controlled Trials as Topic; Vomiting | 1996 |
[A new antiemetic ramosetron hydrochloride].
Topics: Animals; Antiemetics; Antineoplastic Agents; Benzimidazoles; Granisetron; Guinea Pigs; Humans; Male; Nausea; Ondansetron; Serotonin Antagonists; Vomiting | 1997 |
[Recent improvements in antiemetic therapy].
Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Drug Therapy, Combination; Granisetron; Humans; Indoles; Metoclopramide; Nausea; Ondansetron; Phenothiazines; Serotonin Antagonists; Tropisetron; Vomiting | 1997 |
5-HT3-receptor antagonists: a review of pharmacology and clinical efficacy.
Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Nausea; Ondansetron; Serotonin Antagonists; Vomiting | 1997 |
New drugs in the management of the irritable bowel syndrome.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Antidiarrheals; Benzyl Compounds; Colonic Diseases, Functional; Female; Gastrointestinal Agents; Gastrointestinal Transit; Granisetron; Humans; Leuprolide; Male; Octreotide; Ondansetron; Propylamines; Receptors, Opioid, kappa; Serotonin Antagonists | 1998 |
Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting: a quantitative systematic review.
Topics: Antiemetics; Granisetron; Humans; Nausea; Ondansetron; Radiotherapy; Randomized Controlled Trials as Topic; Serotonin Antagonists; Treatment Outcome; Vomiting | 1998 |
Antiemetic therapy for high-dose chemotherapy with transplantation: report of a retrospective analysis of a 5-HT(3) regimen and literature review.
Topics: Administration, Oral; Adrenal Cortex Hormones; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Antipsychotic Agents; Bone Marrow Transplantation; Drug Combinations; Granisetron; Humans; Infusions, Intravenous; Nausea; Ondansetron; Phenothiazines; Retrospective Studies; Safety; Serotonin Antagonists; Transplantation Conditioning; Treatment Outcome; Vomiting | 1999 |
Granisetron is equivalent to ondansetron for prophylaxis of chemotherapy-induced nausea and vomiting: results of a meta-analysis of randomized controlled trials.
Topics: Antiemetics; Antineoplastic Agents; Cross-Over Studies; Granisetron; Humans; Nausea; Neoplasms; Ondansetron; Randomized Controlled Trials as Topic; Serotonin Antagonists; Therapeutic Equivalency; Vomiting | 2000 |
The cardiotoxic potential of the 5-HT(3) receptor antagonist antiemetics: is there cause for concern?
Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Drug Interactions; Electrocardiography; Granisetron; Heart Failure; Humans; Indoles; Middle Aged; Nausea; Neoplasms; Ondansetron; Quinolizines; Serotonin Antagonists; Vomiting | 2002 |
Progress in preventing chemotherapy-induced nausea and vomiting.
Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Granisetron; Humans; Indoles; Nausea; Neurotransmitter Agents; Ondansetron; Quinolizines; Vomiting | 2002 |
Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists.
Topics: Antiemetics; Antineoplastic Agents; Aprepitant; Cisplatin; Clinical Trials, Phase II as Topic; Drug Therapy, Combination; Granisetron; Humans; Morpholines; Neoplasms; Neurokinin-1 Receptor Antagonists; Neurotransmitter Agents; Ondansetron; Prodrugs; Serotonin; Serotonin Antagonists; Substance P; Vomiting | 2003 |
Effects of aprepitant on the pharmacokinetics of ondansetron and granisetron in healthy subjects.
Topics: Adult; Antiemetics; Aprepitant; Area Under Curve; Cross-Over Studies; Drug Interactions; Female; Granisetron; Half-Life; Humans; Male; Middle Aged; Morpholines; Ondansetron; Randomized Controlled Trials as Topic | 2003 |
Electrocardiographic and cardiovascular effects of the 5-hydroxytryptamine3 receptor antagonists.
Topics: Antiemetics; Cardiovascular System; Clinical Trials as Topic; Dose-Response Relationship, Drug; Electrocardiography; Granisetron; Humans; Indoles; Ondansetron; Quinolizines; Serotonin Antagonists; Surgical Procedures, Operative | 2003 |
Granisetron: new insights into its use for the treatment of chemotherapy-induced nausea and vomiting.
Topics: Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Granisetron; Humans; Indoles; Nausea; Ondansetron; Quinolizines; Serotonin Antagonists; Vomiting | 2003 |
[Serotonin and anticancer drug-induced emesis].
Topics: Animals; Antiemetics; Antineoplastic Agents; Cisplatin; Enterochromaffin Cells; Granisetron; Humans; Indoles; Ondansetron; Receptors, Serotonin, 5-HT3; Receptors, Serotonin, 5-HT4; Serotonin; Serotonin 5-HT3 Receptor Antagonists; Serotonin 5-HT4 Receptor Antagonists; Serotonin Antagonists; Tropisetron; Vagus Nerve; Vomiting | 2004 |
First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron.
Topics: Age Factors; Aged; Antiemetics; Drug Resistance; Granisetron; Humans; Nausea; Neoplasms; Ondansetron; Radiotherapy; Receptors, Dopamine; Serotonin Antagonists; Vomiting | 2004 |
Update on anti-emetics for chemotherapy-induced emesis.
Topics: Administration, Oral; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Australia; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Granisetron; Humans; Indoles; Isoquinolines; Male; Neoplasms; Ondansetron; Palonosetron; Patient Satisfaction; Prognosis; Quality of Life; Quinolizines; Quinuclidines; Treatment Outcome; Tropisetron; Vomiting | 2005 |
The role of 5-HT3 receptor antagonists in preventing postoperative nausea and vomiting.
Topics: Adult; Algorithms; Antiemetics; Child; Dexamethasone; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Evidence-Based Medicine; Granisetron; Humans; Indoles; Isoquinolines; Nurse's Role; Nursing Assessment; Ondansetron; Operating Room Nursing; Palonosetron; Patient Selection; Postoperative Nausea and Vomiting; Practice Guidelines as Topic; Quinolizines; Quinuclidines; Risk Assessment; Risk Factors; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists | 2006 |
The efficacy of 5-HT3 receptor antagonists for the prevention of postoperative nausea and vomiting after craniotomy: a meta-analysis.
Topics: Antiemetics; Craniotomy; Data Interpretation, Statistical; Granisetron; Humans; Indoles; Ondansetron; Postoperative Nausea and Vomiting; Randomized Controlled Trials as Topic; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Treatment Outcome; Tropisetron | 2007 |
A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis.
Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Indoles; Ondansetron; Quinolizines; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome; Tropisetron; Vomiting | 2007 |
Is ondansetron more effective than granisetron for chemotherapy-induced nausea and vomiting? A review of comparative trials.
Topics: Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Evidence-Based Medicine; Granisetron; Humans; Meta-Analysis as Topic; Nausea; Ondansetron; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Research Design; Serotonin Antagonists; Treatment Outcome; Vomiting | 2007 |
[Prophylaxis of chemotherapy-induced vomiting and nausea].
Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Agents; Aprepitant; Granisetron; Humans; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Ondansetron; Primary Prevention; Serotonin 5-HT3 Receptor Antagonists; Time Factors; Vomiting | 2008 |
[Management of chemotherapy-induced emesis: what is the standard after 20 years of clinical research].
Topics: Antineoplastic Combined Chemotherapy Protocols; Benchmarking; Dexamethasone; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Granisetron; Humans; Indoles; Metoclopramide; Nausea; Ondansetron; Premedication; Randomized Controlled Trials as Topic; Research; Serotonin 5-HT3 Receptor Antagonists; Tropisetron; Vomiting | 1998 |
Serotonin receptor antagonists for highly emetogenic chemotherapy in adults.
Topics: Adult; Dexamethasone; Granisetron; Humans; Isoquinolines; Nausea; Ondansetron; Palonosetron; Quinuclidines; Randomized Controlled Trials as Topic; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2010 |
Comparison of the efficacy of ondansetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis.
Topics: Antiemetics; Cholecystectomy, Laparoscopic; Granisetron; Headache Disorders; Humans; Ondansetron; Postoperative Nausea and Vomiting; Randomized Controlled Trials as Topic; Sample Size; Treatment Outcome | 2013 |
Selective serotonin 3 receptor antagonist treatment for schizophrenia: meta-analysis and systematic review.
Topics: Antipsychotic Agents; Constipation; Double-Blind Method; Drug Therapy, Combination; Granisetron; Haloperidol; Humans; Indoles; Nausea; Ondansetron; Randomized Controlled Trials as Topic; Receptors, Serotonin, 5-HT3; Risperidone; Schizophrenia; Serotonin 5-HT3 Receptor Antagonists; Severity of Illness Index; Symptom Assessment; Treatment Outcome; Tropisetron; Vomiting | 2014 |
WITHDRAWN: Serotonin receptor antagonists for highly emetogenic chemotherapy in adults.
Topics: Adult; Dexamethasone; Granisetron; Humans; Isoquinolines; Nausea; Ondansetron; Palonosetron; Quinuclidines; Randomized Controlled Trials as Topic; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2013 |
5-Hydroxytryptamine3 receptor antagonists and cardiac side effects.
Topics: Aged; Antiemetics; Antineoplastic Agents; Cardiovascular Diseases; Granisetron; Humans; Isoquinolines; Long QT Syndrome; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2014 |
Prevention of cisplatin-based chemotherapy-induced delayed nausea and vomiting using triple antiemetic regimens: a mixed treatment comparison.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Cisplatin; Dexamethasone; Drug Therapy, Combination; Granisetron; Humans; Isoquinolines; Morpholines; Nausea; Neoplasms; Network Meta-Analysis; Ondansetron; Palonosetron; Quinuclidines; Randomized Controlled Trials as Topic; Spiro Compounds; Treatment Outcome; Vomiting | 2016 |
Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis.
Topics: Adult; Anesthesia, General; Antiemetics; Benzimidazoles; Granisetron; Humans; Isoquinolines; Ondansetron; Palonosetron; Postoperative Nausea and Vomiting; Quinuclidines; Randomized Controlled Trials as Topic; Serotonin Antagonists; Treatment Outcome | 2016 |
Dexamethasone combined with other antiemetics versus single antiemetics for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: An updated systematic review and meta-analysis.
Topics: Antiemetics; Benzimidazoles; Cholecystectomy, Laparoscopic; Dexamethasone; Drug Therapy, Combination; Granisetron; Humans; Isoquinolines; Metoclopramide; Ondansetron; Palonosetron; Postoperative Nausea and Vomiting; Quinuclidines; Randomized Controlled Trials as Topic | 2016 |
5-HT3 receptor antagonists for the prevention of postoperative shivering: a meta-analysis.
Topics: Analgesics, Opioid; Granisetron; Humans; Indoles; Isoquinolines; Meperidine; Ondansetron; Palonosetron; Postoperative Complications; Postoperative Period; Quinuclidines; Randomized Controlled Trials as Topic; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Antagonists; Shivering; Surgical Procedures, Operative; Tropisetron | 2016 |
Antiemetics in Children With Acute Gastroenteritis: A Meta-analysis.
Topics: Acute Disease; Antiemetics; Child; Child, Preschool; Dexamethasone; Diarrhea; Dimenhydrinate; Domperidone; Fluid Therapy; Gastroenteritis; Granisetron; Hospitalization; Humans; Infant; Metoclopramide; Network Meta-Analysis; Ondansetron; Randomized Controlled Trials as Topic; Regression Analysis; Vomiting | 2020 |
Pharmacological augmentation of serotonin reuptake inhibitors in patients with obsessive-compulsive disorder: A network meta-analysis.
Topics: Bayes Theorem; Drug Therapy, Combination; Granisetron; Humans; Lamotrigine; Memantine; Network Meta-Analysis; Obsessive-Compulsive Disorder; Ondansetron; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2023 |
80 trial(s) available for ondansetron and granisetron
| Article | Year |
|---|---|
A double-blind, randomised, crossover comparison of granisetron and ondansetron in 5-day fractionated chemotherapy: assessment of efficacy, safety and patient preference. The Granisetron Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cross-Over Studies; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Vomiting | 1994 |
Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis. The Granisetron Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Salvage Therapy; Vomiting | 1995 |
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trial.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Cisplatin; Drug Administration Schedule; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Prospective Studies; Vomiting | 1994 |
Effect of metoclopramide, ondansetron and granisetron on aldosterone secretion in man.
Topics: Adult; Aldosterone; Granisetron; Humans; Indazoles; Male; Metoclopramide; Ondansetron; Receptors, Serotonin; Reference Values; Serotonin Antagonists; Single-Blind Method | 1993 |
5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy--a randomised study.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Neoplasms; Ondansetron; Patient Satisfaction; Prospective Studies; Receptors, Serotonin; Serotonin Antagonists; Tropisetron; Vomiting | 1993 |
Ondansetron versus granisetron, both combined with dexamethasone, in the prevention of cisplatin-induced emesis. Italian Group of Antiemetic Research.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Double-Blind Method; Drug Administration Routes; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Ondansetron; Prospective Studies; Vomiting | 1995 |
Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Drug Administration Schedule; Female; Granisetron; Head and Neck Neoplasms; Humans; Indoles; Male; Middle Aged; Nausea; Ondansetron; Prospective Studies; Serotonin Antagonists; Tropisetron; Vomiting | 1996 |
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Granisetron; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Middle Aged; Nausea; Ondansetron; Prospective Studies; Vomiting | 1995 |
An open randomised cross-over study on granisetron versus ondansetron in the prevention of acute emesis induced by moderate dose cisplatin-containing regimens.
Topics: Acute Disease; Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Cross-Over Studies; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Vomiting | 1996 |
Granisetron (IV) compared with ondansetron (IV plus oral) in the prevention of nausea and vomiting induced by moderately-emetogenic chemotherapy. A cross-over study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Drug Administration Schedule; Female; Granisetron; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Ondansetron; Treatment Outcome; Vomiting | 1995 |
Prevention of delayed emesis by a single intravenous bolus dose of 5-HT3-receptor-antagonist in moderately emetogenic chemotherapy.
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Cost-Benefit Analysis; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Granisetron; Granulocyte Colony-Stimulating Factor; Humans; Indoles; Injections, Intravenous; Methotrexate; Middle Aged; Ondansetron; Serotonin Antagonists; Tropisetron; Vomiting | 1996 |
A pilot study to evaluate the cost-effectiveness of ondansetron and granisetron in fractionated total body irradiation.
Topics: Administration, Oral; Antiemetics; Bone Marrow Transplantation; Cost-Benefit Analysis; Drug Administration Schedule; Evaluation Studies as Topic; Follow-Up Studies; Granisetron; Humans; Injections, Intravenous; Leukemia; Lymphoma, Non-Hodgkin; Ondansetron; Pilot Projects; Radiotherapy Dosage; Time Factors; Transplantation Conditioning; Vomiting; Whole-Body Irradiation | 1996 |
Prophylactic antiemetic therapy with ondansetron, tropisetron, granisetron and metoclopramide in patients undergoing laparoscopic cholecystectomy: a randomized, double-blind comparison with placebo.
Topics: Adult; Aged; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Female; Granisetron; Humans; Indoles; Male; Metoclopramide; Middle Aged; Nausea; Ondansetron; Postoperative Complications; Prospective Studies; Serotonin Antagonists; Tropisetron; Vomiting | 1996 |
Comparison of Granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer. A randomized controlled trial.
Topics: Acute Disease; Antiemetics; Antineoplastic Agents; Cisplatin; Data Interpretation, Statistical; Granisetron; Humans; Indoles; Nausea; Ondansetron; Randomized Controlled Trials as Topic; Tropisetron | 1996 |
Cardiovascular effects of i.v. granisetron at two administration rates and of ondansetron in healthy adults.
Topics: Adult; Antiemetics; Double-Blind Method; Drug Interactions; Electrocardiography; Female; Granisetron; Headache; Heart; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Ondansetron | 1997 |
Anti-emetic drug effects on cognitive and psychomotor performance: granisetron vs. ondansetron.
Topics: Adolescent; Adult; Affect; Antiemetics; Cognition; Cross-Over Studies; Double-Blind Method; Drug Monitoring; Female; Granisetron; Humans; Male; Nausea; Ondansetron; Psychomotor Performance; Radiotherapy; Vomiting | 1997 |
Patients' self-reported functional status after granisetron or ondansetron therapy to prevent chemotherapy-induced nausea and vomiting at six cancer centers.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Vomiting | 1997 |
Anti-emetic drug effects on pilot performance: granisetron vs. ondansetron.
Topics: Administration, Oral; Adult; Aerospace Medicine; Affect; Antiemetics; Attention; Cross-Over Studies; Double-Blind Method; Drug Monitoring; Granisetron; Humans; Male; Military Personnel; Motion Sickness; Ondansetron; Psychomotor Performance | 1997 |
A comparative study of intravenous granisetron versus intravenous and oral ondansetron in the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy.
Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Agents; Drug Administration Schedule; Female; Granisetron; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Ondansetron; Prospective Studies; Vomiting | 1997 |
Progress in reducing anticipatory nausea and vomiting: a study of community practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Treatment Outcome; Vomiting | 1998 |
Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Carboplatin; Cyclophosphamide; Dexamethasone; Double-Blind Method; Female; Granisetron; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Nausea; Ondansetron; Vomiting | 1998 |
Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Double-Blind Method; Female; Granisetron; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Ondansetron | 1998 |
Comparison of antiemetic efficacy of granisetron and ondansetron in Oriental patients: a randomized crossover study.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cross-Over Studies; Double-Blind Method; Granisetron; Hong Kong; Humans; Middle Aged; Nausea; Ondansetron; Vomiting | 1998 |
Continuous-infusion granisetron compared to ondansetron for the prevention of nausea and vomiting after high-dose chemotherapy.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Double-Blind Method; Female; Granisetron; Humans; Infusions, Intravenous; Middle Aged; Nausea; Ondansetron; Serotonin Antagonists; Treatment Outcome; Vomiting | 1998 |
Granisetron and ondansetron for chemotherapy-related nausea and vomiting.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Treatment Outcome; Vomiting | 1998 |
[Granisetron (per os) compared with ondansetron (per os) in the prevention of nausea and vomiting induced by mildly emetogenic chemotherapies. Groupe de Recherches en Cancerologie du Nord].
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cross-Over Studies; Cyclophosphamide; Doxorubicin; Female; Granisetron; Humans; Male; Methotrexate; Nausea; Ondansetron; Prednisone; Vindesine; Vomiting | 1998 |
Heterogeneity in systemic availability of ondansetron and granisetron following oral administration.
Topics: Administration, Oral; Adult; Antiemetics; Area Under Curve; Biological Availability; Cross-Over Studies; Female; Granisetron; Humans; Male; Middle Aged; Ondansetron; Serotonin Antagonists | 1999 |
Serotonin receptor antagonists in prophylaxis of acute and delayed emesis induced by moderately emetogenic, single-day chemotherapy: a randomized study.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Ondansetron; Prospective Studies; Serotonin Antagonists; Tropisetron; Vomiting | 1999 |
[Comparative trial of oral granisetron and intravenous ondansetron in patients receiving chemotherapy for breast cancer. Study Group of Granisetron].
Topics: Administration, Oral; Adult; Aged; Antiemetics; Breast Neoplasms; Drug Therapy, Combination; Female; Granisetron; Humans; Injections, Intravenous; Male; Metoclopramide; Middle Aged; Nausea; Ondansetron; Vomiting | 1999 |
Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisetron and ondansetron.
Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Female; Granisetron; Humans; Hydroxyindoleacetic Acid; Male; Microdialysis; Middle Aged; Neoplasms; Ondansetron; Serotonin; Serotonin Antagonists; Vomiting | 1999 |
A prospective randomized trial of the anti-emetic efficacy of ondansetron and granisetron during bone marrow transplantation.
Topics: Adolescent; Adult; Aged; Antiemetics; Bone Marrow Transplantation; Child; Child, Preschool; Dexamethasone; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Prospective Studies; Vomiting | 1999 |
Granisetron, tropisetron, and ondansetron in the prevention of acute emesis induced by a combination of cisplatin-Adriamycin and by high-dose ifosfamide delivered in multiple-day continuous infusions.
Topics: Acute Disease; Adolescent; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Doxorubicin; Drug Administration Schedule; Extremities; Female; Granisetron; Humans; Ifosfamide; Indoles; Male; Ondansetron; Osteosarcoma; Tropisetron; Vomiting | 2000 |
Comparison of granisetron, ondansetron and tropisetron for control of vomiting and nausea induced by cisplatin.
Topics: Adult; Antiemetics; Antineoplastic Agents; Cisplatin; Cost-Benefit Analysis; Female; Granisetron; Humans; Indoles; Injections, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Treatment Outcome; Tropisetron; Vomiting, Anticipatory | 2000 |
Comparative efficacy of three 5-HT3 antagonists (granisetron, ondansetron, and tropisetron) plus dexamethasone for the prevention of cisplatin-induced acute emesis: a randomized crossover study.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Cross-Over Studies; Dexamethasone; Female; Granisetron; Head and Neck Neoplasms; Humans; Indoles; Injections, Intravenous; Male; Middle Aged; Ondansetron; Patient Satisfaction; Treatment Outcome; Tropisetron; Vomiting | 2000 |
[Effects of oral 5-HT3 antagonists on chemotherapy-induced emesis in patients with gynecologic cancers].
Topics: Administration, Oral; Antiemetics; Benzimidazoles; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Genital Neoplasms, Female; Granisetron; Humans; Indoles; Middle Aged; Nausea; Ondansetron; Paclitaxel; Serotonin Antagonists; Tropisetron; Vomiting | 2000 |
The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Granisetron; Humans; Life Tables; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Neoplasm Staging; Ondansetron; Prognosis; Risk; Skin Neoplasms; Survival Analysis; Tamoxifen; Treatment Outcome; Vomiting | 2000 |
Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation.
Topics: Adult; Aged; Antiemetics; Bone Marrow Transplantation; Double-Blind Method; Drug Evaluation; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Serotonin Antagonists; Whole-Body Irradiation | 2000 |
Randomised double blind crossover study comparing ondansetron, granisetron and tropisetron. A cost-benefit analysis.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cost-Benefit Analysis; Cross-Over Studies; Drug Costs; Female; Granisetron; Health Care Costs; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Treatment Outcome; Tropisetron; Vomiting | 2000 |
Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Serotonin Antagonists; Vomiting | 2000 |
Randomized, multicenter comparison of oral granisetron and oral ondansetron for emetogenic chemotherapy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Dexamethasone; Drug Therapy, Combination; Emetics; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron | 2000 |
The effects of serotonin (5-HT3) receptor antagonists on gastric tachyarrhythmia and the symptoms of motion sickness.
Topics: Adolescent; Adult; Antiemetics; Cross-Over Studies; Double-Blind Method; Electrodiagnosis; Female; Gastrointestinal Motility; Granisetron; Humans; Male; Motion Sickness; Nystagmus, Optokinetic; Ondansetron; Rotation; Serotonin Antagonists; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2000 |
Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Indoles; Lymphoma; Male; Melphalan; Nausea; Ondansetron; Serotonin Antagonists; Transplantation, Autologous; Tropisetron; Vomiting | 2000 |
Randomized trial of ondansetron, granisetron, and tropisetron in the prevention of acute nausea and vomiting.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Indoles; Leukemia; Male; Multiple Myeloma; Myelodysplastic Syndromes; Nausea; Ondansetron; Transplantation, Autologous; Transplantation, Homologous; Tropisetron; Vomiting | 2000 |
Effective cross-over to granisetron after failure to ondansetron, a randomized double blind study in patients failing ondansetron plus dexamethasone during the first 24 hours following highly emetogenic chemotherapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cross-Over Studies; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Ondansetron; Vomiting | 2001 |
Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
Topics: Administration, Oral; Antiemetics; Costs and Cost Analysis; Double-Blind Method; Female; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Ondansetron; Serotonin Antagonists; Therapeutic Equivalency; Transplantation Conditioning; Vomiting | 2001 |
The development of a protocol for the use of 5-HT3 antagonists in chemotherapy-induced nausea and vomiting.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Clinical Protocols; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Treatment Outcome; Tropisetron; Vomiting | 2001 |
[Nausea disintegrating buccal tablet in the prevention of gastrointestinal reaction induced by anticancer drugs].
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Digestive System; Doxorubicin; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Tablets; Treatment Outcome; Vomiting | 2002 |
Antiemetic effectiveness of ondansetron and granisetron in patients with breast cancer treated with cyclophosphamide.
Topics: Adult; Antiemetics; Antineoplastic Agents; Breast Neoplasms; Cancer Care Facilities; Cohort Studies; Cyclophosphamide; Dexamethasone; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Granisetron; Humans; Infusions, Intravenous; Injections, Intravenous; Logistic Models; Middle Aged; Nausea; Ondansetron; Retrospective Studies; Time Factors; Vomiting | 2004 |
Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial.
Topics: Antiemetics; Double-Blind Method; Female; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nausea; Ondansetron; Prospective Studies; Transplantation Conditioning; Vomiting | 2004 |
Granisetron and ondansetron for prevention of nausea and vomiting in patients undergoing modified radical mastectomy.
Topics: Adult; Aged; Analysis of Variance; Anesthesia, General; Breast Neoplasms; Chi-Square Distribution; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Granisetron; Humans; Infusions, Intravenous; Mastectomy, Modified Radical; Middle Aged; Nausea; Ondansetron; Preoperative Care; Probability; Reference Values; Risk Assessment; Treatment Outcome; Vomiting | 2004 |
The effects of ondansetron and granisetron on electrocardiography in children receiving chemotherapy for acute leukemia.
Topics: Adolescent; Antiemetics; Antimetabolites, Antineoplastic; Child; Child, Preschool; Electrocardiography; Female; Granisetron; Heart Rate; Humans; Male; Methotrexate; Nausea; Ondansetron; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Serotonin Antagonists; Vomiting | 2005 |
A randomized, double-blind study of granisetron plus dexamethasone versus ondansetron plus dexamethasone to prevent postoperative nausea and vomiting in patients undergoing abdominal hysterectomy.
Topics: Adult; Aged; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Hysterectomy; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting | 2005 |
Electrocardiographic findings after 5-HT3 receptor antagonists and chemotherapy in children with cancer.
Topics: Adolescent; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Electrocardiography; Female; Granisetron; Heart Rate; Humans; Male; Nausea; Neoplasms; Ondansetron; Predictive Value of Tests; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome | 2006 |
Association of the ABCB1 3435C>T polymorphism with antiemetic efficacy of 5-hydroxytryptamine type 3 antagonists.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; ATP-Binding Cassette Transporters; Female; Gene Frequency; Genotype; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Polymorphism, Single Nucleotide; Prospective Studies; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Time Factors; Treatment Outcome; Tropisetron; Vomiting | 2005 |
The use of oral granisetron versus intravenous ondansetron for antiemetic prophylaxis in patients undergoing laparoscopic surgery: the effect on emetic symptoms and quality of recovery.
Topics: Administration, Oral; Adult; Anesthesia Recovery Period; Antiemetics; Double-Blind Method; Female; Granisetron; Humans; Injections, Intravenous; Laparoscopy; Male; Ondansetron; Patient Satisfaction; Postoperative Nausea and Vomiting; Statistics, Nonparametric | 2006 |
Skipping day 2 antiemetic medications may improve chemotherapy induced delayed nausea and vomiting control: results of two pilot phase II trials.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Brazil; Dexamethasone; Drug Hypersensitivity; Female; Granisetron; Humans; Hypersensitivity, Delayed; Logistic Models; Male; Metoclopramide; Middle Aged; Nausea; Ondansetron; Pilot Projects; Quality of Life; Research Design; Serotonin Antagonists; Treatment Outcome; Vomiting | 2007 |
Does ondansetron or granisetron prevent subarachnoid morphine-induced pruritus after cesarean delivery?
Topics: Adult; Antipruritics; Cesarean Section; Female; Granisetron; Humans; Injections, Spinal; Morphine; Ondansetron; Pregnancy; Pruritus; Subarachnoid Space | 2007 |
[A randomized double-blind study of prevention of postoperative nausea and vomiting with ondansetron, tropisetron, or granisetron in patients undergoing general anesthesia].
Topics: Adolescent; Adult; Aged; Anesthesia, General; Antiemetics; Double-Blind Method; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Tropisetron; Young Adult | 2007 |
Granisetron versus ondansetron treatment for breakthrough postoperative nausea and vomiting after prophylactic ondansetron failure: a pilot study.
Topics: Adult; Cross-Over Studies; Female; Granisetron; Humans; Middle Aged; Ondansetron; Pilot Projects; Postoperative Nausea and Vomiting; Time Factors; Treatment Failure | 2007 |
Ondansetron, granisetron, and dexamethasone compared for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy : A randomized placebo-controlled study.
Topics: Adult; Aged; Antiemetics; Cholecystectomy, Laparoscopic; Dexamethasone; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Gallbladder Diseases; Granisetron; Humans; Incidence; Injections, Intravenous; Male; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Preoperative Care; Treatment Outcome; United States | 2008 |
Preemptive antiemesis in patients undergoing modified radical mastectomy: oral granisetron versus oral ondansetron in a double-blind, randomized, controlled study.
Topics: Adolescent; Adult; Aged; Antiemetics; Double-Blind Method; Female; Granisetron; Humans; Mastectomy, Modified Radical; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Preanesthetic Medication | 2007 |
Comparison of the effectiveness of metoclopramide, ondansetron, and granisetron on the prevention of nausea and vomiting after laparoscopic cholecystectomy.
Topics: Adult; Aged; Analysis of Variance; Antiemetics; Chi-Square Distribution; Cholecystectomy, Laparoscopic; Double-Blind Method; Female; Granisetron; Humans; Male; Metoclopramide; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Treatment Outcome | 2007 |
A randomized, double-blinded comparison of ondansetron, granisetron, and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy.
Topics: Adult; Antiemetics; Craniotomy; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Prospective Studies; Supratentorial Neoplasms | 2009 |
Reduction of severity of pruritus after elective caesarean section under spinal anaesthesia with subarachnoid morphine: a randomised comparison of prophylactic granisetron and ondansetron.
Topics: Adult; Analgesics, Opioid; Anesthesia, Obstetrical; Anesthesia, Spinal; Cesarean Section; Double-Blind Method; Elective Surgical Procedures; Female; Granisetron; Humans; Injections; Morphine; Ondansetron; Pain Measurement; Patient Satisfaction; Postoperative Complications; Postoperative Nausea and Vomiting; Pregnancy; Pruritus; Serotonin Antagonists; Subarachnoid Space | 2010 |
Combination therapy in the prevention of PONV after strabismus surgery in children: granisetron, ondansetron, midazolam with dexamethasone.
Topics: Antiemetics; Child; Child, Preschool; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Midazolam; Ondansetron; Postoperative Nausea and Vomiting; Strabismus | 2009 |
Dexamethasone with either granisetron or ondansetron for postoperative nausea and vomiting in laparoscopic surgery.
Topics: Adult; Antiemetics; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Laparoscopy; Male; Metoclopramide; Middle Aged; Ondansetron; Patient Satisfaction; Postoperative Nausea and Vomiting; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2010 |
Antiemetic prophylaxis in thyroid surgery: a randomized, double-blind comparison of three 5-HT3 agents.
Topics: Adult; Aged; Antiemetics; Double-Blind Method; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Preanesthetic Medication; Serotonin 5-HT3 Receptor Antagonists; Thyroidectomy; Tropisetron; Young Adult | 2011 |
[Preventive efficacy of ondansetron and granisetron for postoperative nausea and vomiting in high risk patients].
Topics: Adolescent; Adult; Aged; Antiemetics; Double-Blind Method; Female; Granisetron; Humans; Male; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Treatment Outcome; Young Adult | 2011 |
Ondansetron versus granisetron in the prevention of chemotherapy induced nausea and vomiting in children with acute lymphoblastic leukemia.
Topics: Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Double-Blind Method; Female; Granisetron; Humans; Male; Nausea; Ondansetron; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Serotonin Antagonists; Vomiting | 2011 |
Comparison of palanosetron, granisetron and ondansetron as anti-emetics for prevention of postoperative nausea and vomiting in patients undergoing middle ear surgery.
Topics: Adult; Antiemetics; Ear, Middle; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Ondansetron; Palonosetron; Postoperative Nausea and Vomiting; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists | 2011 |
Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV).
Topics: Antiemetics; Antineoplastic Agents; Double-Blind Method; Female; Granisetron; Humans; Indoles; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinolizines; Quinuclidines; Serotonin Antagonists; Treatment Outcome; Vomiting | 2014 |
Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting over multiple cycles of moderately or highly emetogenic chemotherapy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Neurokinin-1 Receptor Antagonists; Ondansetron; Randomized Controlled Trials as Topic; Retreatment; Serotonin 5-HT3 Receptor Antagonists; Spiro Compounds; Treatment Outcome; Vomiting; Young Adult | 2016 |
APF530 (granisetron injection extended-release) in a three-drug regimen for delayed CINV in highly emetogenic chemotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Delayed-Action Preparations; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Injections, Subcutaneous; Male; Middle Aged; Morpholines; Nausea; Ondansetron; Treatment Outcome; Vomiting; Young Adult | 2016 |
Sequential addition of aprepitant in patients receiving carboplatin-based chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Aprepitant; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Dexamethasone; Female; Granisetron; Humans; Lung Neoplasms; Male; Middle Aged; Morpholines; Nausea; Ondansetron; Paclitaxel; Pemetrexed; Vomiting | 2016 |
Efficacy of Palonosetron as Antiemetic Prophylaxis for Post Operative Patients.
Topics: Administration, Intravenous; Adult; Anesthesia, General; Antiemetics; Bangladesh; Cholecystectomy, Laparoscopic; Double-Blind Method; Granisetron; Humans; Middle Aged; Ondansetron; Palonosetron; Postoperative Complications; Postoperative Nausea and Vomiting; Prospective Studies; Serotonin 5-HT3 Receptor Antagonists | 2019 |
Comparing the efficacy of ondansetron and granisetron augmentation in treatment-resistant obsessive-compulsive disorder: a randomized double-blind placebo-controlled study.
Topics: Double-Blind Method; Granisetron; Obsessive-Compulsive Disorder; Ondansetron; Serotonin Antagonists | 2019 |
A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiation.
Topics: Administration, Cutaneous; Adult; Antiemetics; Antineoplastic Agents; Cancer Survivors; Endometrial Neoplasms; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Ondansetron; Quality of Life; Remission Induction; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vomiting | 2021 |
Efficacy of the granisetron transdermal system for the control of nausea and vomiting induced by highly emetogenic chemotherapy: a multicenter, randomized, controlled trial.
Topics: Antiemetics; Antineoplastic Agents; Double-Blind Method; Granisetron; Humans; Nausea; Ondansetron; Quality of Life; Vomiting | 2023 |
Effect of Dexmedetomidine, Dexamethasone, and Ondansetron on Postoperative Nausea and Vomiting in Children Undergoing Dental Rehabilitation: A Randomized Controlled Trial.
Topics: Adult; Antiemetics; Child; Dexamethasone; Dexmedetomidine; Double-Blind Method; Granisetron; Humans; Ondansetron; Postoperative Nausea and Vomiting; Prospective Studies | 2023 |
Effects of ondansetron, metoclopramide and granisetron on perioperative nausea and vomiting in patients undergone bariatric surgery: a randomized clinical trial.
Topics: Antiemetics; Bariatric Surgery; Double-Blind Method; Granisetron; Humans; Metoclopramide; Ondansetron; Postoperative Nausea and Vomiting | 2023 |
142 other study(ies) available for ondansetron and granisetron
| Article | Year |
|---|---|
Development of high-affinity 5-HT3 receptor antagonists. 1. Initial structure-activity relationship of novel benzamides.
Topics: Animals; Antiemetics; Benzamides; Benzofurans; Binding, Competitive; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cerebral Cortex; Cisplatin; Ferrets; Granisetron; Imidazoles; Indazoles; Indoles; Male; Metoclopramide; Molecular Structure; Ondansetron; Rats; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship; Vomiting | 1992 |
5-HT3 receptor antagonists. 1. New quinoline derivatives.
Topics: Animals; Male; Quinolines; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship; Tumor Cells, Cultured | 1992 |
Development of high-affinity 5-HT3 receptor antagonists. 2. Two novel tricyclic benzamides.
Topics: Amides; Animals; Antiemetics; Benzamides; Benzofurans; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cerebral Cortex; Cisplatin; Dogs; Ferrets; Guinea Pigs; Ileum; Molecular Structure; Muscle Contraction; Rats; Serotonin; Serotonin Antagonists; Structure-Activity Relationship; Vomiting; X-Ray Diffraction | 1992 |
Synthesis and biochemical evaluation of tritium-labeled 1-methyl-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxa mide, a useful radioligand for 5HT3 receptors.
Topics: Animals; Cell Membrane; Cerebral Cortex; Guinea Pigs; Heart Rate; Ileum; Indazoles; Male; Methylation; Myocardium; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Structure-Activity Relationship; Tritium; Tropanes | 1990 |
Conformation-activity relationship study of 5-HT3 receptor antagonists and a definition of a model for this receptor site.
Topics: Animals; Binding Sites; Guinea Pigs; Mice; Protein Conformation; Rabbits; Rats; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship | 1990 |
5-Hydroxytryptamine (5-HT3) receptor antagonists. 1. Indazole and indolizine-3-carboxylic acid derivatives.
Topics: Animals; Antiemetics; Carboxylic Acids; Ferrets; Guinea Pigs; Ileum; In Vitro Techniques; Indazoles; Indicators and Reagents; Indolizines; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Molecular Structure; Muscle Contraction; Muscle, Smooth; Pyrazoles; Rats; Receptors, Serotonin; Reflex; Serotonin; Serotonin Antagonists; Stereoisomerism; Structure-Activity Relationship | 1990 |
5-HT3 receptor antagonists. 3. Quinoline derivatives which may be effective in the therapy of irritable bowel syndrome.
Topics: Animals; Carboxylic Acids; Castor Oil; Colon; Colonic Diseases, Functional; Defecation; Diarrhea; Disease Models, Animal; Gastrointestinal Agents; Gastrointestinal Transit; Male; Quinolines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Serotonin; Serotonin Antagonists; Stress, Physiological; Structure-Activity Relationship; Thyrotropin-Releasing Hormone | 1993 |
Development of high-affinity 5-HT3 receptor antagonists. Structure-affinity relationships of novel 1,7-annelated indole derivatives.
Topics: Animals; Carbazoles; Cell Membrane; Cerebral Cortex; Guinea Pigs; Ileum; Imidazoles; Indoles; Models, Molecular; Molecular Conformation; Molecular Structure; Ondansetron; Pyridines; Rats; Receptors, Serotonin; Serotonin Antagonists; Stereoisomerism; Structure-Activity Relationship; Vagus Nerve | 1993 |
2-(Quinuclidin-3-yl)pyrido[4,3-b]indol-1-ones and isoquinolin-1-ones. Potent conformationally restricted 5-HT3 receptor antagonists.
Topics: Animals; Cisplatin; Computer Simulation; Dogs; Ferrets; Isoquinolines; Male; Models, Molecular; Molecular Structure; Palonosetron; Pyridones; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin Antagonists; Stereoisomerism; Structure-Activity Relationship; Vomiting | 1993 |
5-HT3 receptor antagonists. 2. 4-Hydroxy-3-quinolinecarboxylic acid derivatives.
Topics: Animals; Antiemetics; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cisplatin; Dogs; Guinea Pigs; Heart Rate; Hydrogen Bonding; Magnetic Resonance Spectroscopy; Male; Mice; Models, Molecular; Molecular Structure; Ondansetron; Quinolines; Quipazine; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Structure-Activity Relationship; Vomiting | 1993 |
Phenylimidazolidin-2-one derivatives as selective 5-HT3 receptor antagonists and refinement of the pharmacophore model for 5-HT3 receptor binding.
Topics: Animals; Binding, Competitive; Brain; Guinea Pigs; Heart Rate; Ileum; Imidazoles; Models, Molecular; Molecular Structure; Muscles; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists | 1997 |
5-HT3 antagonists derived from aminopyridazine-type muscarinic M1 agonists.
Topics: Animals; Brain Stem; Hippocampus; In Vitro Techniques; Models, Molecular; Muscarinic Agonists; Myocardium; Protein Conformation; Pyridazines; Rats; Receptors, Muscarinic; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists | 1998 |
Benzimidazole derivatives. 2. Synthesis and structure-activity relationships of new azabicyclic benzimidazole-4-carboxylic acid derivatives with affinity for serotoninergic 5-HT(3) receptors.
Topics: Animals; Benzimidazoles; Cell Membrane; Cerebral Cortex; Electric Stimulation; Guinea Pigs; Ileum; Male; Molecular Structure; Muscle Contraction; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Structure-Activity Relationship | 1999 |
The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective alpha7 nicotinic receptor partial agonist.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Cell Membrane; Hippocampus; Indoles; Inhibitory Concentration 50; Intestine, Small; Ligands; Membrane Potentials; Mice; Nicotinic Agonists; Oocytes; Protein Binding; Rats; Receptors, Nicotinic; Serotonin Antagonists; Structure-Activity Relationship; Tropisetron; Xenopus | 2001 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.
Topics: Animals; Cell Line; Disease Models, Animal; Humans; Imidazoles; Indoles; Irritable Bowel Syndrome; Mice; Microsomes, Liver; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Agonists | 2011 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
Novel D
Topics: Animals; Antipsychotic Agents; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; Schizophrenia | 2022 |
Are all 5-HT3 receptor antagonists the same?
Topics: Animals; Antiemetics; Cisplatin; Dose-Response Relationship, Drug; Ferrets; Granisetron; Imidazoles; Indazoles; Ondansetron; Serotonin Antagonists; Vomiting; Whole-Body Irradiation | 1992 |
Morphine 6-glucuronide: a metabolite of morphine with greater emetic potency than morphine in the ferret.
Topics: Animals; Cyclophosphamide; Dose-Response Relationship, Drug; Emetics; Ferrets; Granisetron; Imidazoles; Indazoles; Injections, Subcutaneous; Morphine; Morphine Derivatives; Naloxone; Ondansetron; Vomiting | 1992 |
[High affinity binding of Y-25130 for serotonin 3 receptor].
Topics: Animals; Antiemetics; Binding, Competitive; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cerebral Cortex; Granisetron; In Vitro Techniques; Indazoles; Male; Ondansetron; Oxazines; Rats; Rats, Wistar; Receptors, Serotonin; Synaptic Membranes | 1992 |
The budgetary impact of 5-HT3 receptor antagonists in the management of chemotherapy-induced emesis.
Topics: Antiemetics; Antineoplastic Agents; Drug Costs; Granisetron; Humans; Indazoles; Models, Theoretical; Nausea; Ondansetron; Serotonin Antagonists; Vomiting | 1992 |
Actions of serotonin antagonists on cholera-toxin-induced intestinal fluid secretion.
Topics: Animals; Body Fluids; Cholera Toxin; Female; Granisetron; Imidazoles; Indazoles; Intestinal Mucosa; Ketanserin; Lysergic Acid Diethylamide; Male; Methysergide; Ondansetron; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists; Zimeldine | 1992 |
Profiles of interaction of R(+)/S(-)-zacopride and anxiolytic agents in a mouse model.
Topics: Animals; Anti-Anxiety Agents; Antiemetics; Behavior, Animal; Benzamides; Brain Chemistry; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Chlordiazepoxide; Fenclonine; Granisetron; Indazoles; Male; Mice; Neurotransmitter Agents; Ondansetron; Receptors, Cholecystokinin; Receptors, Serotonin; Ritanserin; Serotonin Antagonists; Stereoisomerism | 1992 |
Who should receive a 5-HT3 antagonist?
Topics: Acute Disease; Antineoplastic Agents; Granisetron; Humans; Indazoles; Nausea; Ondansetron; Serotonin Antagonists; Vomiting | 1992 |
5-HT3 receptor blockers.
Topics: Granisetron; Humans; Imidazoles; Indazoles; Ondansetron; Receptors, Serotonin; Vagus Nerve | 1991 |
Pharmacologic profile of (R)-5-[(1-methyl-3-indolyl)carbonyl]-4,5,6,7-tetrahydro-1H- benzimidazole hydrochloride (YM060), a potent and selective 5-hydroxytryptamine3 receptor antagonist, and its enantiomer in the isolated tissue.
Topics: Animals; Benzimidazoles; Dogs; Female; Granisetron; Guinea Pigs; Imidazoles; Indazoles; Male; Muscle, Smooth; Muscle, Smooth, Vascular; Myocardial Contraction; Ondansetron; Receptors, Adrenergic; Receptors, Histamine; Serotonin Antagonists; Stereoisomerism | 1991 |
Preliminary evidence for the involvement of the putative 5-HT4 receptor in zacopride- and copper sulphate-induced vomiting in the ferret.
Topics: Analysis of Variance; Animals; Antiemetics; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Copper; Copper Sulfate; Female; Ferrets; Granisetron; Imidazoles; Indazoles; Indoles; Loperamide; Male; Ondansetron; Receptors, Serotonin; Serotonin Antagonists; Tropisetron; Vomiting | 1991 |
Evidence that the amygdala is involved in the disinhibitory effects of 5-HT3 receptor antagonists.
Topics: Amygdala; Animals; Anxiety; Conflict, Psychological; Granisetron; Imidazoles; Indazoles; Indoles; Lighting; Male; Ondansetron; Raphe Nuclei; Rats; Serotonin; Serotonin Antagonists; Social Behavior; Tropanes; Tropisetron | 1991 |
Effects of 5-hydroxytryptamine 3 receptor antagonists on gastrointestinal motor activity in conscious dogs.
Topics: Animals; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Digestion; Dogs; Dose-Response Relationship, Drug; Female; Gastrointestinal Motility; Granisetron; Imidazoles; Indazoles; Indoles; Infusions, Intravenous; Injections, Intravenous; Male; Motilin; Motor Activity; Muscle Contraction; Muscle, Smooth; Ondansetron; Serotonin Antagonists; Time Factors; Tropisetron | 1991 |
Involvement of 5-hydroxytryptamine 3 receptors in regulation of interdigestive gastric contractions by motilin in the dog.
Topics: Acetylcholine; Animals; Digestion; Dogs; Gastrointestinal Motility; Granisetron; Imidazoles; Indazoles; Motilin; Muscle Contraction; Muscle, Smooth; Ondansetron; Receptors, Serotonin; Serotonin Antagonists; Stomach | 1991 |
Serotonin antagonists: a new class of antiemetic agents.
Topics: Antiemetics; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Granisetron; Humans; Imidazoles; Indazoles; Indoles; Metoclopramide; Ondansetron; Quinolizines; Receptors, Serotonin; Serotonin Antagonists; Tropanes; Tropisetron; Vomiting | 1991 |
RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
Topics: Administration, Oral; Animals; Antiemetics; Antineoplastic Agents; Benzofurans; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bridged-Ring Compounds; Cisplatin; Dogs; Dopamine; Ferrets; Gastric Emptying; Granisetron; Imidazoles; Indazoles; Ondansetron; Receptors, Serotonin; Serotonin Antagonists; Vomiting | 1990 |
The effects of granisetron, ICS 205-930 and ondansetron on the visceral pain reflex induced by duodenal distension.
Topics: Animals; Blood Pressure; Duodenum; Granisetron; Imidazoles; Indazoles; Indoles; Male; Morphine; Muscle Contraction; Muscle, Smooth; Ondansetron; Pain; Pyrazoles; Rats; Rats, Inbred Strains; Reflex; Serotonin Antagonists; Stomach; Tropisetron; Vagotomy | 1990 |
Lack of effects of 5HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat.
Topics: Animals; Anxiety; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Chlordiazepoxide; Granisetron; Imidazoles; Indazoles; Male; Motor Activity; Ondansetron; Rats; Serotonin Antagonists; Social Behavior | 1989 |
[Effect of 5-HT3 receptor antagonists on gastrointestinal motility].
Topics: Animals; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Dogs; Gastrointestinal Motility; Granisetron; Imidazoles; In Vitro Techniques; Indazoles; Indoles; Motilin; Ondansetron; Rabbits; Serotonin Antagonists; Tropisetron | 1989 |
Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), granisetron and ondansetron in rat vagus nerve and cerebral cortex.
Topics: Animals; Benzimidazoles; Cerebral Cortex; Dose-Response Relationship, Drug; Electrophysiology; Granisetron; Kinetics; Male; Ondansetron; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Vagus Nerve | 1995 |
Interaction of the antiemetics ondansetron and granisetron with the cytotoxicity induced by irradiation, epirubicin, bleomycin, estramustine, and cisplatin in vitro.
Topics: Animals; Antibiotics, Antineoplastic; Antiemetics; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bleomycin; Cells, Cultured; Cisplatin; Cricetinae; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Interactions; Epirubicin; Estramustine; Fibroblasts; Granisetron; Humans; Lung Neoplasms; Ondansetron; Serotonin Antagonists; Tumor Cells, Cultured | 1995 |
Molecular surface comparison. 2. Similarity of electrostatic vector fields in drug design.
Topics: Anti-Anxiety Agents; Benzamides; Benzazepines; Bridged Bicyclo Compounds, Heterocyclic; Carbolines; Diazepam; Drug Design; Electricity; GABA-A Receptor Agonists; Granisetron; Indoles; Isomerism; Molecular Conformation; Ondansetron; Pharmaceutical Preparations; Protein Binding; Pyrazoles; Pyridazines; Receptors, Drug; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Structure-Activity Relationship; Surface Properties; Triazolam; Tropisetron | 1995 |
The piglet as a suitable animal model for studying the delayed phase of cisplatin-induced emesis.
Topics: Animals; Cisplatin; Disease Models, Animal; Female; Granisetron; Male; Nausea; Ondansetron; Swine; Time Factors; Vomiting | 1995 |
5HT3 receptor antagonists do not block nicotine induced hyperactivity in rats.
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Granisetron; Haloperidol; Indoles; Male; Motor Activity; Nicotine; Ondansetron; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Time Factors; Tropanes; Tropisetron | 1995 |
Serotonin-induced vasodilatation in the human forearm is mediated by the "nitric oxide-pathway": no evidence for involvement of the 5-HT3-receptor.
Topics: Adult; Amino Acid Oxidoreductases; Arginine; Forearm; Free Radical Scavengers; Granisetron; Guanylate Cyclase; Humans; Indazoles; Male; Methylene Blue; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Ondansetron; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Vasodilation | 1993 |
Pharmacological characterization of RS 25259-197, a novel and selective 5-HT3 receptor antagonist, in vivo.
Topics: Administration, Oral; Animals; Bradycardia; Dogs; Dose-Response Relationship, Drug; Duodenum; Female; Ferrets; Granisetron; Hemodynamics; Injections, Intravenous; Injections, Subcutaneous; Isoquinolines; Male; Ondansetron; Palonosetron; Quinuclidines; Random Allocation; Rats; Serotonin; Serotonin Antagonists; Stereoisomerism; Vomiting | 1995 |
Cost effectiveness of 5-hydroxytryptamine3 receptor antagonists: a retrospective comparison of ondansetron and granisetron.
Topics: Antineoplastic Agents; Cost-Benefit Analysis; Drug Administration Schedule; Granisetron; Humans; Ondansetron; Retrospective Studies; Vomiting | 1995 |
Serotonin (5-HT)3-receptor antagonism of 4,5,6,7-tetrahydrobenzimidazole derivatives against 5-HT-induced bradycardia in anesthetized rats.
Topics: Animals; Benzimidazoles; Bradycardia; Colon; Disease Models, Animal; Dose-Response Relationship, Drug; Granisetron; Guinea Pigs; In Vitro Techniques; Indolizines; Injections, Intravenous; Male; Muscle Contraction; Muscle, Smooth; Ondansetron; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Structure-Activity Relationship | 1994 |
Block of the delayed rectifier current (IK) by the 5-HT3 antagonists ondansetron and granisetron in feline ventricular myocytes.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cats; Granisetron; Heart Ventricles; In Vitro Techniques; Myocardium; Ondansetron; Patch-Clamp Techniques; Potassium Channels; Serotonin Antagonists | 1994 |
Characterisation of the cytochrome P450 enzymes involved in the in vitro metabolism of granisetron.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Granisetron; Humans; Hydroxylation; In Vitro Techniques; Indoles; Isoenzymes; Kinetics; Microsomes, Liver; Ondansetron; Serotonin Antagonists; Tropisetron | 1994 |
Antagonists at the serotonin-3 receptor can reduce the fear-potentiated startle response in the rat: evidence for different types of anxiolytic activity?
Topics: Animals; Anti-Anxiety Agents; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Buspirone; Diazepam; Fear; Granisetron; Male; Ondansetron; Rats; Reflex, Startle; Serotonin Antagonists | 1994 |
Relative costs of granisetron and ondansetron.
Topics: Cost Savings; Drug Costs; Granisetron; Humans; Ondansetron | 1994 |
Plasma levels of peptide YY correlate with cisplatin-induced emesis in dogs.
Topics: Animals; Cisplatin; Dogs; Drug Interactions; Drug Therapy, Combination; Female; Granisetron; Immunoenzyme Techniques; Ondansetron; Peptide YY; Peptides; Radioimmunoassay; Random Allocation; Serotonin; Vomiting | 1994 |
Comparison of potencies of 5-HT3 receptor antagonists at inhibiting aversive behavior to illumination and the von Bezold-Jarisch reflex in the mouse.
Topics: Animals; Behavior, Animal; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Dose-Response Relationship, Drug; Granisetron; Heart Rate; Lighting; Mice; Motor Activity; Ondansetron; Reflex; Serotonin Antagonists; Stereoisomerism | 1994 |
Granisetron and ondansetron: effects on the ileal brake mechanism in the rat.
Topics: Animals; Dose-Response Relationship, Drug; Gastrointestinal Transit; Granisetron; Ileum; Indazoles; Lipids; Male; Ondansetron; Rats; Sensitivity and Specificity; Serotonin Antagonists | 1993 |
The effects of orally administered Y-25130, a selective serotonin3-receptor antagonist, on chemotherapeutic agent-induced emesis.
Topics: Administration, Oral; Animals; Antiemetics; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cisplatin; Cyclophosphamide; Dogs; Domperidone; Dose-Response Relationship, Drug; Doxorubicin; Female; Ferrets; Granisetron; Male; Metoclopramide; Ondansetron; Oxazines; Serotonin Antagonists; Vomiting | 1993 |
Pharmacological properties of KF18259, a novel 5-HT3-receptor antagonist, in rats: inhibition of the distal colonic function.
Topics: Animals; Benzimidazoles; Cisplatin; Colon; Defecation; Gastric Emptying; Gastrointestinal Motility; Granisetron; Male; Ondansetron; Quinolines; Rats; Rats, Sprague-Dawley; Reflex; Serotonin; Serotonin Antagonists | 1993 |
Synthesis of 2-piperazinylbenzothiazole and 2-piperazinylbenzoxazole derivatives with 5-HT3 antagonist and 5-HT4 agonist properties.
Topics: Animals; Benzothiazoles; Binding, Competitive; Cerebral Cortex; Female; Gastric Emptying; Granisetron; Guinea Pigs; Ileum; Male; Molecular Structure; Mucous Membrane; Ondansetron; Piperazines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Thiazoles | 1994 |
The effects of different antiemetic agents on morphine-induced emesis in ferrets.
Topics: Anesthesia; Animals; Antiemetics; Droperidol; Ferrets; Granisetron; Injections, Intravenous; Isoflurane; Male; Metoclopramide; Morphine; Naloxone; Ondansetron; Vomiting | 1993 |
Inhibition of 5-hydroxytryptamine- and enterotoxin-induced fluid secretion by 5-HT receptor antagonists in the rat jejunum.
Topics: Animals; Bacterial Toxins; Body Fluids; Cholera Toxin; Enterotoxins; Escherichia coli; Escherichia coli Proteins; Female; Granisetron; Indoles; Jejunum; Ketanserin; Ondansetron; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Tropisetron | 1993 |
5-HT3 receptor antagonists inhibit morphine-induced stimulation of mesolimbic dopamine release and function in the rat.
Topics: Animals; Behavior, Animal; Dialysis; Dopamine; Dose-Response Relationship, Drug; Granisetron; Indazoles; Indoles; Limbic System; Male; Morphine; Ondansetron; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Tropisetron | 1993 |
Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron.
Topics: Animals; Benzamides; Biguanides; Binding Sites; Binding, Competitive; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Membrane; Glioma; Granisetron; Indazoles; Kinetics; Neuroblastoma; Ondansetron; Quipazine; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tritium | 1993 |
'... setron': are 5-HT3 receptor antagonists different?
Topics: Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Indoles; Male; Ondansetron; Receptors, Serotonin; Serotonin Antagonists; Tropisetron; Vomiting | 1993 |
BRL 46470 potently antagonizes neural responses activated by 5-HT3 receptors.
Topics: Animals; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Electrophysiology; Glioma; Granisetron; In Vitro Techniques; Indoles; Kinetics; Male; Neuroblastoma; Neurons; Ondansetron; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Tropisetron; Tubocurarine; Tumor Cells, Cultured; Vagus Nerve | 1993 |
Development of potent serotonin-3 (5-HT3) receptor antagonists. II. Structrue-activity relationships of N-(1-benzyl-4-methylhexahydro-1H-1,4- diazepin-6-yl)carboxamides.
Topics: Animals; Bradycardia; Granisetron; Injections, Intravenous; Magnetic Resonance Spectroscopy; Male; Mice; Models, Molecular; Ondansetron; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Structure-Activity Relationship; Vomiting | 1995 |
Hypersensitivity reactions associated with 5- hydroxytryptamine(3)-receptor antagonists: a class effect?
Topics: Aged; Antiemetics; Drug Hypersensitivity; Female; Granisetron; Humans; Indoles; Middle Aged; Ondansetron; Serotonin Antagonists; Tropisetron | 1996 |
Retention behaviour of anti-emetic serotonin antagonists in reversed phase high performance liquid chromatography.
Topics: Antiemetics; Chromatography, High Pressure Liquid; Granisetron; Indoles; Ondansetron; Serotonin Antagonists; Tropisetron | 1995 |
Effect of serotonin (5-HT)3-receptor antagonists YM060, YM114 (KAE-393), ondansetron and granisetron on 5-HT4 receptors and gastric emptying in rodents.
Topics: Animals; Benzimidazoles; Cisplatin; Dose-Response Relationship, Drug; Gastric Emptying; Granisetron; Guinea Pigs; Male; Ondansetron; Rats; Rats, Wistar; Serotonin Antagonists | 1995 |
Re: 'Cost-effectiveness of 5-hydroxytryptamin3 receptor antagonists: a retrospective comparison of ondansetron and granisetron'.
Topics: Cost-Benefit Analysis; Granisetron; Nausea; Ondansetron; Salvage Therapy; Serotonin Antagonists; Vomiting | 1996 |
5HT3 receptor antagonists and pruritus due to cholestasis.
Topics: Aged; Breast Neoplasms; Cholestasis; Female; Granisetron; Humans; Liver Neoplasms; Ondansetron; Pruritus; Serotonin Antagonists | 1996 |
Tardive dyskinesia as a result of long-term prochlorperazine use.
Topics: Antiemetics; Dopamine Antagonists; Dyskinesia, Drug-Induced; Fatal Outcome; Female; Granisetron; Humans; Middle Aged; Nausea; Ondansetron; Prochlorperazine; Time Factors; Vomiting | 1996 |
Correction: chemical structures of serotonin and serotonin-receptor antagonists.
Topics: Granisetron; Humans; Models, Structural; Ondansetron; Product Labeling; Serotonin Antagonists | 1996 |
[Role of 5-HT3 receptors in the control by cholecystokinin of transient relaxations of the inferior esophageal sphincter in dogs].
Topics: Animals; Cholecystokinin; Dogs; Dose-Response Relationship, Drug; Esophagogastric Junction; Granisetron; Male; Manometry; Muscle Relaxation; Ondansetron; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists | 1996 |
Use of dexamethasone with 5-HT3-receptor antagonists.
Topics: Antiemetics; Dexamethasone; Drug Therapy, Combination; Granisetron; Humans; Ondansetron; Serotonin Antagonists; Vomiting | 1996 |
Participation of 5-HT3, 5-HT4, and nicotinic receptors in the peristaltic reflex of guinea pig distal colon.
Topics: Animals; Colon; Granisetron; Guinea Pigs; Hexamethonium; Imidazoles; In Vitro Techniques; Indoles; Male; Muscle, Smooth; Ondansetron; Peristalsis; Receptors, Nicotinic; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Receptors, Serotonin, 5-HT4; Serotonin Antagonists | 1996 |
The activity of dihydropyrimidine dehydrogenase from rat liver was not affected by any of five 5-hydroxytryptamine antagonists.
Topics: Animals; Antiemetics; Antimetabolites, Antineoplastic; Biotransformation; Bridged Bicyclo Compounds, Heterocyclic; Cytosol; Dihydrouracil Dehydrogenase (NADP); Fluorouracil; Granisetron; Indoles; Liver; Male; Ondansetron; Oxazines; Oxidoreductases; Quinolizines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Tropisetron | 1996 |
Effect of 5-HT2 and 5-HT3 receptor antagonists on cholera toxin-induced fluid hypersecretion in the pig jejunum.
Topics: Analysis of Variance; Animals; Cholera Toxin; Dose-Response Relationship, Drug; Granisetron; Indoles; Jejunal Diseases; Jejunum; Ketanserin; Ondansetron; Serotonin Antagonists; Swine; Swine Diseases; Tropisetron | 1996 |
Response heterogeneity of 5-HT3 receptor antagonists in a rat visceral hypersensitivity model.
Topics: Animals; Benzamides; Bridged Bicyclo Compounds, Heterocyclic; Colon; Granisetron; Indoles; Male; Muscle Contraction; Muscle, Smooth; Ondansetron; Pain; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Tropisetron | 1996 |
Always more "setrons": how many do we need?
Topics: Antiemetics; Antineoplastic Agents; Drug Costs; Granisetron; Humans; Indoles; Nausea; Ondansetron; Serotonin Antagonists; Tropisetron; Vomiting | 1997 |
Effects of gastroprokinetic agents on gastroparesis in streptozotocin-induced diabetic rats.
Topics: Animals; Benzamides; Benzimidazoles; Blood Glucose; Cisapride; Diabetes Mellitus, Experimental; Gastric Emptying; Gastrointestinal Motility; Gastroparesis; Granisetron; Male; Morpholines; Ondansetron; Piperidines; Pyrroles; Rats; Rats, Wistar; Serotonin Antagonists; Serotonin Receptor Agonists; Vagotomy | 1997 |
5-HT-induced colonic contractions: enteric locus of action and receptor subtypes.
Topics: Animals; Atropine; Colon; Dogs; Granisetron; Hexamethonium; Infusions, Intra-Arterial; Methysergide; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Ondansetron; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Tetrodotoxin | 1997 |
Fighting nausea in the '90s: more and better anti-emetics can help.
Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Synergism; Drug Therapy, Combination; Granisetron; Humans; Isonipecotic Acids; Nausea; Ondansetron; Serotonin Antagonists; Substance P; Vomiting | 1997 |
Evidence for a 5-HT3 receptor involvement in the facilitation of peristalsis on mucosal application of 5-HT in the guinea pig isolated ileum.
Topics: Animals; Dioxanes; Female; Granisetron; Guinea Pigs; Ileum; In Vitro Techniques; Male; Methiothepin; Mucous Membrane; Ondansetron; Peristalsis; Piperidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Ritanserin; Serotonin; Serotonin Antagonists | 1997 |
Assuring the optimal use of serotonin antagonist antiemetics: the process for development and implementation of institutional antiemetic guidelines at Memorial Sloan-Kettering Cancer Center.
Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Utilization; Female; Granisetron; Guideline Adherence; Humans; Male; Nausea; Ondansetron; Practice Guidelines as Topic; Quality Assurance, Health Care; Serotonin Antagonists; Vomiting | 1998 |
Anti-emetic effect of ondansetron and granisetron after exposure to mixed neutron and gamma irradiation.
Topics: Animals; Antiemetics; Gamma Rays; Granisetron; Macaca fascicularis; Male; Nausea; Neutrons; Ondansetron; Radiation Injuries, Experimental; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Vomiting | 1998 |
5-HT3 receptors are not involved in conditioned taste aversions induced by 5-hydroxytryptamine, ipecacuanha or cisplatin.
Topics: Animals; Antineoplastic Agents; Avoidance Learning; Cisplatin; Conditioning, Classical; Drinking Behavior; Granisetron; Ipecac; Male; Ondansetron; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Antagonists; Taste | 1998 |
Bidirectional allosteric modulation of strychnine-sensitive glycine receptors by tropeines and 5-HT3 serotonin receptor ligands.
Topics: Allosteric Regulation; Animals; Benzofurans; Binding, Competitive; Bridged Bicyclo Compounds, Heterocyclic; Glycine; Granisetron; Indoles; Ligands; Male; Medulla Oblongata; Ondansetron; Pons; Rats; Rats, Wistar; Receptors, Glycine; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serotonin Receptor Agonists; Spinal Cord; Strychnine; Tropanes; Tropisetron; Tubocurarine | 1998 |
Surrogate outcomes: meaningful not!
Topics: Anesthesia; Antiemetics; Granisetron; Humans; Indoles; Ondansetron; Postoperative Nausea and Vomiting; Quinolizines | 1999 |
Antiemetic therapy in managed care oncology: roundtable discussion.
Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Managed Care Programs; Medicare; Ondansetron; Reimbursement, Incentive; Serotonin Antagonists; United States; Vomiting | 1996 |
Serotoninergic modulation of cell volume response to estramustine: an image-analysis study on perifused individual glioma cells.
Topics: Cell Size; Drug Combinations; Drug Interactions; Estramustine; Glioma; Granisetron; Humans; Ondansetron; Serotonin; Serotonin Antagonists; Tumor Cells, Cultured | 1999 |
Improvement of cisplatin-induced emesis and delayed gastric emptying by KB-R6933, a novel 5-HT3 receptor antagonist.
Topics: Animals; Antiemetics; Antineoplastic Agents; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Cisplatin; Dose-Response Relationship, Drug; Ferrets; Gastric Emptying; Granisetron; Male; Ondansetron; Oxazines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Vomiting | 1999 |
Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum.
Topics: Animals; Benzimidazoles; Dose-Response Relationship, Drug; Drug Interactions; Ferrets; Granisetron; Ileum; Male; Ondansetron; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 1999 |
Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels.
Topics: Antiemetics; Cation Transport Proteins; Cell Line; Cloning, Molecular; DNA-Binding Proteins; Dose-Response Relationship, Drug; Electric Stimulation; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Granisetron; Heart; Humans; Indoles; KCNQ Potassium Channels; KCNQ1 Potassium Channel; Ondansetron; Potassium Channels; Potassium Channels, Voltage-Gated; Quinolizines; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Sodium Channels; Trans-Activators; Transcriptional Regulator ERG; Transfection | 2000 |
Pharmacological characterization of the 5-HT receptor-mediated contraction in the mouse isolated ileum.
Topics: Animals; Atropine; Dioxanes; Dose-Response Relationship, Drug; Female; Granisetron; Ileum; In Vitro Techniques; Indoles; Ketanserin; Male; Mice; Muscle Contraction; Ondansetron; Piperidines; Receptors, Serotonin; Ritanserin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tetrodotoxin; Tropanes; Tropisetron | 2000 |
Evaluation of outcomes in converting from intravenous ondansetron to oral granisetron: an observational study.
Topics: Administration, Oral; Adolescent; Adult; Antiemetics; Child; Constipation; Diarrhea; Drug Utilization Review; Drug-Related Side Effects and Adverse Reactions; Female; Granisetron; Guideline Adherence; Headache; Humans; Injections, Intravenous; Male; Middle Aged; Ondansetron; Organizational Policy; Treatment Outcome | 2001 |
Possible involvement of 5-HT4 receptors, in addition to 5-HT3 receptors, in the emesis induced by high-dose cisplatin in Suncus murinus.
Topics: Animals; Antiemetics; Antineoplastic Agents; Cisplatin; Granisetron; Indoles; Male; Ondansetron; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Receptors, Serotonin, 5-HT4; Serotonin Antagonists; Shrews; Sulfonamides; Tropisetron; Vomiting | 2001 |
Diverging effects of 5-HT3 receptor antagonists ondansetron and granisetron on estramustine-inhibited cellular potassium transport.
Topics: Antiemetics; Antineoplastic Agents; Biological Transport; Bumetanide; Chlorides; Drug Interactions; Estramustine; Granisetron; Humans; K Cl- Cotransporters; Lung Neoplasms; Mesothelioma; Ondansetron; Ouabain; Potassium; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Sodium; Sodium-Potassium-Exchanging ATPase; Symporters; Time Factors; Tumor Cells, Cultured | 2001 |
Effects of ondansetron, granisetron, ramosetron, and azasetron on human neutrophil functions.
Topics: Antiemetics; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Chemotaxis, Leukocyte; Granisetron; Humans; Neutrophils; Ondansetron; Oxazines | 2002 |
Effectiveness of serotonin-receptor antagonist antiemetic therapy over successive courses of carboplatin-based chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carboplatin; Clinical Trials as Topic; Dexamethasone; Drug Administration Schedule; Female; Genital Neoplasms, Female; Granisetron; Humans; Middle Aged; Nausea; Ondansetron; Retrospective Studies; Serotonin Antagonists; Taxoids; Vomiting | 2002 |
Granisetron vs ondansetron: is it a question of duration of 5-HT3 receptor blockade?
Topics: Afferent Pathways; Antiemetics; Antineoplastic Agents; Cisplatin; Clinical Trials as Topic; Cross-Over Studies; Dose-Response Relationship, Drug; Granisetron; Half-Life; Humans; Ondansetron; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Research Design; Serotonin Antagonists; Vagus Nerve; Vomiting; Vomiting, Anticipatory | 2002 |
Ondansetron but not granisetron affect cell volume regulation and potassium ion transport of glioma cells treated with estramustine phosphate.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Size; Estramustine; Glioma; Granisetron; Humans; Ion Transport; Ondansetron; Potassium; Rubidium Radioisotopes; Serotonin; Serotonin Antagonists; Sodium; Sodium-Potassium-Chloride Symporters; Sodium-Potassium-Exchanging ATPase; Tumor Cells, Cultured | 2002 |
Pharmacological characterization of the 5-HT1A, 5-HT2 and 5-HT3 receptors in the bovine ciliary muscle.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Binding, Competitive; Cattle; Cell Membrane; Ciliary Body; Dose-Response Relationship, Drug; Granisetron; In Vitro Techniques; Ketanserin; Muscle Contraction; Muscle, Smooth; Ondansetron; Radioligand Assay; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tritium | 2003 |
Action of 5-HT3 receptor antagonists and dexamethasone to modify cisplatin-induced emesis in Suncus murinus (house musk shrew).
Topics: Animals; Antiemetics; Cisplatin; Dexamethasone; Drug Therapy, Combination; Esophagus; Female; Granisetron; Injections, Intraperitoneal; Male; Ondansetron; Serotonin 5-HT3 Receptor Antagonists; Shrews; Vagotomy; Vomiting | 2003 |
Compatibility of granisetron hydrochloride with selected alkaline drugs.
Topics: Antiemetics; Chemistry, Pharmaceutical; Drug Incompatibility; Granisetron; Hydrogen-Ion Concentration; Ondansetron | 1995 |
Central nervous system side-effects of 5-HT3-receptor antagonists in elderly cancer patients treated with chemotherapy.
Topics: Aged; Antineoplastic Agents; Central Nervous System Diseases; Clinical Trials as Topic; Granisetron; Humans; Neoplasms; Ondansetron; Serotonin Antagonists | 2004 |
Facilitation of cholinergic transmission by combined treatment of ondansetron with flumazenil after cortical cholinergic deafferentation.
Topics: Acetylcholine; Afferent Pathways; Animals; Cerebral Cortex; Denervation; Flumazenil; GABA Agonists; GABA Modulators; GABA-A Receptor Antagonists; Granisetron; Male; Muscimol; Ondansetron; Parasympathetic Nervous System; Potassium; Rats; Rats, Wistar; Receptors, GABA-A; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Synaptic Transmission | 2004 |
2005 Medicare payments for chemotherapy will exceed costs.
Topics: Antiemetics; Antineoplastic Agents; Diphosphonates; Drug Costs; Fees, Pharmaceutical; Granisetron; Humans; Medicare; Ondansetron; Pamidronate; United States | 2005 |
Isolated urticaria to ondansetron and successful treatment with granisetron.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Drug Hypersensitivity; Granisetron; Humans; Male; Ondansetron; Pancreatic Neoplasms; Skin Tests; Urticaria | 2005 |
5HT3-receptor antagonists as antiemetics in cancer.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Granisetron; Humans; Indoles; Isoquinolines; Nausea; Neoplasms; Ondansetron; Palonosetron; Practice Guidelines as Topic; Quinolizines; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Tropisetron; Vomiting | 2005 |
Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy.
Topics: Adolescent; Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Confusion; Dexamethasone; Diphenhydramine; Drug Therapy, Combination; Female; Granisetron; Humans; Indoles; Infusion Pumps; Infusions, Intravenous; Length of Stay; Lorazepam; Male; Mood Disorders; Ondansetron; Patient Acceptance of Health Care; Quinolizines; Retrospective Studies; Self Administration; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome; Vomiting | 2007 |
Re: The effects of ondansetron and granisetron on electrocardiography in children receiving chemotherapy for acute leukemia.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Electrocardiography; Granisetron; Heart Rate; Humans; Nausea; Ondansetron; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2005 |
Study of the effect of standardized chemotherapy order forms on prescribing errors and anti-emetic cost.
Topics: Antiemetics; Antineoplastic Agents; Cost-Benefit Analysis; Drug Costs; Drug Prescriptions; Drug Utilization; Forms and Records Control; Granisetron; Medical Errors; Ondansetron; Pharmacy Service, Hospital; Prospective Studies | 2005 |
Luminal hypotonicity increases duodenal mucosal permeability by a mechanism involving 5-hydroxytryptamine.
Topics: Anesthetics, Local; Animals; Cyclooxygenase Inhibitors; Duodenum; Granisetron; Indoles; Indomethacin; Intestinal Mucosa; Lidocaine; Male; Ondansetron; Osmotic Pressure; Piperidines; Rats; Rats, Inbred Strains; Serotonin; Serotonin 5-HT3 Receptor Antagonists; Serotonin 5-HT4 Receptor Antagonists; Serotonin Agents; Serotonin Antagonists; Tetrodotoxin; Tropisetron | 2006 |
Clinical experience with small-dose granisetron and dexamethasone for prevention of postoperative nausea and vomiting.
Topics: Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Hysterectomy; Ondansetron; Postoperative Nausea and Vomiting | 2006 |
Relative efficacy of ondansetron, granisetron, dolasetron and palonosetron in controlling acute nausea and vomiting associated with platinum-based chemotherapy.
Topics: Antiemetics; Granisetron; Humans; Indoles; Isoquinolines; Nausea; Ondansetron; Organoplatinum Compounds; Palonosetron; Quinolizines; Quinuclidines; Treatment Outcome; Vomiting | 2006 |
[Comparison of antiemetic efficacy of 5-HT3 receptor antagonists in orthopedics cancer patients receiving high-dose chemotherapy].
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bone Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Granisetron; Humans; Ifosfamide; Male; Middle Aged; Nausea; Ondansetron; Osteosarcoma; Prospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2007 |
Antiemetic agents.
Topics: Administration, Oral; Anorexia; Antiemetics; Antineoplastic Agents; Aprepitant; Asthenia; Constipation; Diarrhea; Drug Interactions; Dyspepsia; Fatigue; Fever; Granisetron; Headache; Hiccup; Humans; Indoles; Injections, Intravenous; Isoquinolines; Morpholines; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinolizines; Quinuclidines; Vomiting | 2007 |
Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Platinum Compounds; Quinolizines; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2007 |
Cutaneous adverse drug reactions during chemotherapy: consider non-antineoplastic drugs.
Topics: Adult; Antiemetics; Antineoplastic Agents; Breast Neoplasms; Cross Reactions; Drug Eruptions; Female; Glucocorticoids; Granisetron; Humans; Indoles; Male; Middle Aged; Ondansetron; Pancreatic Neoplasms; Prednisolone; Skin Tests; Tropisetron; Urticaria | 2008 |
Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor.
Topics: Animals; Antiemetics; Binding Sites; Calcium; Cell Line; Granisetron; Isoquinolines; Ondansetron; Palonosetron; Postoperative Nausea and Vomiting; Quinuclidines; Radioligand Assay; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Antagonists; Transfection | 2008 |
Receptor occupancy theory-based analysis of interindividual differences in antiemetic effects of 5-HT3 receptor antagonists.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Drug Administration Schedule; Granisetron; Humans; Indoles; Models, Theoretical; Ondansetron; Oxazines; Serotonin 5-HT3 Receptor Antagonists; Treatment Outcome; Tropisetron; Vomiting | 2009 |
Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction.
Topics: Animals; Anorexia; Cisplatin; Drugs, Chinese Herbal; Eating; Gastric Mucosa; Ghrelin; Granisetron; Hypothalamus; Male; Oligopeptides; Ondansetron; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Ghrelin; Reverse Transcriptase Polymerase Chain Reaction; Serotonin 5-HT2 Receptor Antagonists; Stomach | 2010 |
Granisetron or ondansetron for prevention of subarachnoid morphine-induced pruritus after cesarean delivery.
Topics: Adult; Analgesics, Opioid; Antiemetics; Antipruritics; Cesarean Section; Female; Granisetron; Humans; Injections; Morphine; Ondansetron; Pregnancy; Pruritus; Serotonin Antagonists; Subarachnoid Space; Treatment Failure | 2010 |
Anaphylactic reaction owing to ondansetron administration in a child with neuroblastoma and safe use of granisetron: a case report.
Topics: Anaphylaxis; Antiemetics; Antineoplastic Agents; Brain Neoplasms; Female; Granisetron; Humans; Infant; Nausea; Neuroblastoma; Ondansetron; Vomiting | 2010 |
Distinct mechanisms underlying pronociceptive effects of opioids.
Topics: 2-Amino-5-phosphonovalerate; Analgesics, Opioid; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Granisetron; Hyperalgesia; Long-Term Potentiation; Male; Naloxone; Narcotic Antagonists; Nerve Fibers, Unmyelinated; Ondansetron; Pain Threshold; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Somatostatin; Spinal Cord; Substance Withdrawal Syndrome; Synaptic Transmission | 2011 |
Ondansetron and granisetron binding orientation in the 5-HT(3) receptor determined by unnatural amino acid mutagenesis.
Topics: Animals; Binding, Competitive; Granisetron; Mice; Models, Molecular; Ondansetron; Oocytes; Point Mutation; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Xenopus laevis | 2012 |
Is there an association between PONV and chemotherapy-induced nausea and vomiting?
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease Resistance; Droperidol; Epirubicin; Female; Fluorouracil; Granisetron; Humans; Mastectomy; Methotrexate; Metoclopramide; Middle Aged; Models, Biological; Narcotics; Nausea; Ondansetron; Postoperative Nausea and Vomiting; Prospective Studies; Risk Factors; Vomiting | 2013 |
5-HT3 receptor antagonists do not alter spontaneous contraction of pregnant myometrium in vitro.
Topics: Female; Granisetron; Humans; In Vitro Techniques; Indoles; Ondansetron; Pregnancy; Serotonin Antagonists; Tropisetron; Uterine Contraction | 2015 |
Efficacy of granisetron and aprepitant in a patient who failed ondansetron in the prophylaxis of radiation induced nausea and vomiting: a case report.
Topics: Antiemetics; Aprepitant; Bone Neoplasms; Breast Neoplasms; Female; Granisetron; Humans; Middle Aged; Morpholines; Nausea; Neoplasm Metastasis; Ondansetron | 2015 |
Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy-induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Dexamethasone; Drug Therapy, Combination; Female; Gemcitabine; Granisetron; Humans; Isoquinolines; Kidney Neoplasms; Male; Middle Aged; Morpholines; Nausea; Ondansetron; Palonosetron; Quinuclidines; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vomiting | 2015 |
Economic evaluation of 5-HT3 receptor antagonists in combination with dexamethasone for the prevention of 'overall' nausea and vomiting following highly emetogenic chemotherapy in Chinese adult patients.
Topics: Adult; Antiemetics; Antineoplastic Agents; Asian People; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Dexamethasone; Granisetron; Humans; Isoquinolines; Nausea; Ondansetron; Palonosetron; Quinuclidines; Randomized Controlled Trials as Topic; Receptors, Serotonin, 5-HT3; Vomiting | 2017 |
Nausea and vomiting: Therapeutic orphans of pediatric oncology.
Topics: Antiemetics; Child; Child, Preschool; Granisetron; Humans; Methotrexate; Nausea; Ondansetron; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2017 |
A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways.
Topics: Caffeine; Cytochrome P-450 Enzyme System; Diazepam; Female; Granisetron; Humans; Metoprolol; Metronidazole; Midazolam; Models, Biological; Nifedipine; Ondansetron; Pharmaceutical Preparations; Pregnancy | 2018 |
Quantification of ondansetron, granisetron and tropisetron in goat plasma using hydrophilic interaction liquid chromatography-solid phase extraction coupled with hydrophilic interaction liquid chromatography-triple quadrupole tandem mass spectrometry.
Topics: Acetonitriles; Animals; Chromatography, Liquid; Formates; Goats; Granisetron; Hydrophobic and Hydrophilic Interactions; Indoles; Linear Models; Ondansetron; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Tropisetron | 2018 |
Determination of some antiemetic drugs through its native fluorescence or fluorescence quenching of cerrous ammonium sulphate.
Topics: Ammonium Sulfate; Antiemetics; Chemistry, Pharmaceutical; Fluorometry; Granisetron; Hydrolysis; Ondansetron; Quantum Theory; Radiotherapy; Reproducibility of Results; Spectrometry, Fluorescence; Tropisetron | 2020 |
Extrapolation of Adult Efficacy to Pediatric Patients With Chemotherapy-Induced Nausea and Vomiting.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Aprepitant; Child; Child, Preschool; Clinical Trials as Topic; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Drug Dosage Calculations; Female; Granisetron; Humans; Infant; Male; Middle Aged; Nausea; Neurokinin-1 Receptor Antagonists; Ondansetron; Palonosetron; Treatment Outcome; United States; United States Food and Drug Administration; Vomiting; Young Adult | 2020 |
Tropisetron ameliorates cyclophosphamide-induced hemorrhagic cystitis in rats.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Inflammatory Agents; Cyclophosphamide; Cystitis; Disease Models, Animal; Female; Granisetron; Hemorrhage; Inflammation Mediators; Lipid Peroxidation; Nicotinic Agonists; Ondansetron; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Poly(ADP-ribose) Polymerases; Rats, Wistar; Serotonin 5-HT3 Receptor Antagonists; Signal Transduction; STAT3 Transcription Factor; Tropisetron; Urinary Bladder | 2020 |
Effects of 5-HT
Topics: Acute Kidney Injury; Aged; Animals; Benzimidazoles; Cisplatin; Disease Models, Animal; Female; Granisetron; Humans; Kidney; Male; Mice; Middle Aged; Nausea; Ondansetron; Organic Cation Transport Proteins; Palonosetron; Renal Elimination; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2021 |